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Abstract
Chronic kidney disease (CKD) is a significant cause of disability and death in Saint
Lucia. The incidence of CKD is disproportionately higher among individuals who are
socially and financially disadvantaged. New evidence suggests that in resource-poor
countries, government subsidization programs for dialysis treatment aid in the delay of
disease progression and its associated costs. The purpose of this study was to examine the
relationship between health insurance, government subsidization, employment, and
dialysis utilization for CKD patients and the efficacy of subsidization for dialysis in Saint
Lucia. The study included a retrospective cohort of 979 moderate-to-severe CKD patients
from secondary data obtained from the Ministry of Health’s renal registry database.
Dialysis utilization among CKD patients was compared to usage across payment
methods. Categorical data were measured and compared using crosstabulations, chisquare analyses, frequency distributions, and counts between groups. Logistic regression
was applied to control for covariates and compare independent variables. A statistically
significant relationship was found between employment and subsidization and dialysis
utilization among CKD patients but not between insurance and dialysis utilization.
Dialysis utilization among CKD patients in Saint Lucia was heavily influenced by
government subsidization. Policy makers, healthcare officials, and other stakeholders
may obtain information from this study that they can use to develop future initiatives for
payment models and disease management of CKD in Saint Lucia, which may alleviate
some of the financial barriers faced by the country’s CKD patients.
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Section 1: Foundation of the Study and Literature Review
Introduction
Chronic kidney disease (CKD) has become a major contributing factor to the
global burden of disease, with an estimated global prevalence of 11-13% (Hill et al.,
2016; Morton et al., 2017; Nicoll et al., 2018). The prevalence of obesity, diabetes,
hypertension, and CKD in aging populations has a high economic cost for health systems
(Crews et al., 2017; Hill et al., 2016). Despite the increasing prevalence and burden, CKD
remains a low priority within the public health response to noncommunicable diseases in
low-and middle-income countries (LMICs; George et al., 2017; Stanifer et al., 2016).
According to Nicoll (2018), CKD is a significant cause of death and disability
worldwide. Consequently, the incidence of CKD is disproportionately higher among
socially disadvantaged individuals and leads to many negative consequences for these
individuals and their families (Morton et al., 2017). CKD rates are rising in Saint Lucia
compared to the United States due primarily to lifestyle factors such as diet and exercise
(Business View Caribbean, 2019; Ministry of Health, 2019). Additionally, a report by the
Institute for Health Metrics and Evaluation (2018) revealed that some of the top risk
factors for death and disability in Saint Lucia in 2017, as shown in Figure 1, were
diabetes, obesity, and hypertension.
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Figure 1
Top 10 Risks Contributing to Death and Disability in Saint Lucia, 2007-2017

Note. Figure 1 illustrates the top 10 risks contributing to death and disability in Saint
Lucia, all ages combined, for 2007-2017. The graphic shows 2007 and 2017 rankings and
percentage changes. From Saint Lucia, by Institute for Health Metrics and Evaluation,
2018 (http://www.healthdata.org/saint-lucia). CC BY-NC-ND 4.0.
CKD is a progressive noncommunicable disease that cannot be reversed and can
lead to kidney failure or end-stage renal disease (ESRD) if it is not detected and treated
early (Centers for Disease Control and Prevention [CDC], 2019). Significant CKD causes
among adults in Saint Lucia are diabetes and high blood pressure (Pan American Health
Organization [PAHO], 2019). Other risk factors include heart disease, obesity, past
damage to the kidneys, a family history of CKD, and old age (Caribbean Renal Registry,
2018; Government of Saint Lucia, 2018). CKD has varying severity levels, and treatment
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slows progression (Caribbean Renal Registry, 2018; Hill et al., 2016; National Kidney
Foundation [NKF], 2019).
The Caribbean is home to approximately 40 million people, and the majority of
the population lives on islands considered LMICs, such as Saint Lucia. Kramer (2018)
noted that economic, demographic, and health trends in the Caribbean region generally
mirror global changes. A study of the English-speaking Caribbean revealed that CKD is
associated with high morbidity and mortality and places a significant economic burden
and decreased quality of life on affected patients (Meade et al., 2018). In a study carried
out in Jamaica, the largest English-speaking country in the Caribbean, in 2007, of the 968
patients diagnosed with CKD in that year, 576 were on dialysis (Labonté et al., 2017). In
that same year, Antigua reported 43 patients on dialysis (Meade et al., 2018). In 2015,
Saint Lucia had an estimated 85 patients on dialysis between Victoria Hospital and St.
Jude Hospital, with an estimated 85 on the waiting list (Government Information Service
[GIS], 2019). Although most of the English-speaking Caribbean offers dialysis treatment
for CKD patients, Jamaica and Trinidad and Tobago are the only two islands offering
renal transplantation (Labonté et al., 2017). Negative cultural attitudes toward organ
donations are considered a contributing factor to the lack of renal transplantation in other
countries in the region (Kramer et al., 2018).
Consequently, the financial demands of CKD on governments and healthcare
systems reflect global dialysis utilization trends. According to Pallayova et al. (2018),
despite the remarkable global epidemiological changes occurring over the past 30 years,
CKD's prevalence and the associated clinical and economic burden have risen worldwide.
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Additionally, they noted that the fastest growth rates were occurring in LMICs, which
accounts for the increased burden on these countries' governments.
Over the years, Saint Lucia has implemented various programs to address the
CKD health crisis (GIS, 2016). The Ministry of Health has implemented free CKD
screenings and lifestyle and nutrition services at the local level. The transfer of the
national dialysis clinic to the Owen King European Union Hospital in 2008 was a
response to long waiting lists for dialysis treatment (GIS, 2015). Despite these initiatives,
more demands are placed on an already tasked health system due to the development of
comorbidities, such as hypertension, diabetes, heart failure, cardiovascular diseases,
atherosclerosis, and lipid disorders (Kramer et al., 2018). Through the Ministries of
Health and Finance, the Government of Saint Lucia implemented a dialysis subsidization
program for uninsured CKD patients that covers a significant part of dialysis treatment
(GIS, 2016). The Healthcare Amnesty Program includes medication and doctor visits
(GIS, 2016). According to Dr. Merle Clarke, the chief nephrologist on the island, these
efforts have contributed significantly to CKD patients' care in Saint Lucia. However, the
increasing numbers of patients demand more resources and support systems (Victoria
Hospital, 2019).
In this section, I provide an overview of Saint Lucia’s healthcare system and CKD
management on the island. Next, the problem statement, the purpose of the study, the
nature of the study, research questions (RQs) and hypotheses, and the theoretical
framework for the study are discussed. The definitions of terms, assumptions, the scope
and delimitations, and limitations, including threats to validity, are then presented. I
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conclude the chapter by discussing the significance of the study and summarizing key
points.
Background
Saint Lucia is an island state in the Caribbean. The second largest of the
Windward group of islands in the Lesser Antilles, it is 27 miles (43 km) long and 14
miles (23 km) wide, with a population of 183,000 (Government of Saint Lucia, 2018).
The majority (85.3%) of the island’s population is of African descent, followed by 10.8%
mixed, 2.2% East Indian, and 0.6% Amerindian (Carib) population groups (PAHO,
2019). The Ministry of Health is responsible for overseeing the health of the population,
providing finances, issuing regulations, and developing and enforcing public health
policies (Government of Saint Lucia, 2015). Saint Lucia’s health system offers primary
care through a network of wellness centers, polyclinics, and secondary- and tertiary-level
care through public and private hospitals (PAHO, 2019). In the absence of a national
health insurance scheme, payment for health services is based on a fee-for-service system
(St. Lucia News online, 2016). Individuals are free to access care in both the public and
private sectors. Individuals with individual or group health insurance coverage through
employment benefits obtain assistance in paying for health services. Individuals
considered pensioners or having welfare or disability status receive medical aid from the
Ministry of Health. Others assume full financial responsibility due to the lack of
insurance or failure to fall within groups afforded medical assistance (GIS, 2016).
There are four hospitals where patients utilize dialysis treatment on the island:
The Victoria Hospital (respiratory hospital), Owen King European Union Hospital,
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Tapion Hospital in the north of the island, and St. Jude Hospital in the south (Ministry of
Health, 2019). In response to the COVID-19 pandemic, Victoria Hospital was recently
transformed into a Covid hospital and offered dialysis only to admitted patients requiring
such treatment (Ministry of Health, 2020). Before the transformation, Victoria Hospital
was a primary acute care 130-bed hospital, equipped with medical, surgical, maternity,
and pediatric wards; two operating rooms, one intensive care unit; a laboratory; an X-ray
and ultrasound lab; a pharmacy; a physiotherapy department; and a pathology lab
(Ministry of Health, 2019; see also Business View Caribbean, 2019). The Owen King
European Union Hospital is a 120-bed hospital that provides inpatient and outpatient
services (St. Lucia News online, 2016). It also houses the island’s largest dialysis outpatient clinic, which opened in January 2018. This dialysis clinic has 17 nurses and one
nephrologist (Government of Saint Lucia, 2015; Ministry of Health, 2016).
St. Jude Hospital, managed by a board of directors, is a 110-bed hospital with
medical, surgical, maternity, and pediatric wards; two operating rooms; a recovery room;
an intensive care unit; an emergency room; a pharmacy; a laboratory; an X-ray lab; an
ultrasound lab; a pathology lab; and a physiotherapy department (St. Jude Hospital,
2019). St. Jude Hospital’s dialysis clinic currently has eight dialysis machines, 11 nurses,
two attendants, and one secretary. Operating hours are from Sunday to Saturday, and the
clinic follows a shift system, the first running from 6:45 am to 2 pm and the second, 1 pm
to 9 pm. This shift system was developed to benefit and accommodate CKD patients who
are employed (St. Jude Hospital, 2019).
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Tapion Hospital, situated in the north of the island, is a private 32-bed hospital,
with two fully equipped operating rooms and a delivery suite, a laboratory for specimen
testing, and sleep and radiology labs (Tapion Hospital, 2019). It provides specialty
services such as neurosurgery, internal medicine; general surgery; dermatology; ear,
nose, and throat; ophthalmology, pediatrics, orthopedics, oncology, obstetrics, and
gynecology. It is the only hospital with computerized tomography and magnetic
resonance imaging scanners on the island (Tapion Hospital, 2019). The dialysis clinic at
Tapion Hospital has been in operation since 1999. According to Nurse Director Connie
Hager (personal communication, 2019), this private dialysis clinic provides its services to
local and foreign CKD patients. Patients who are insured or willing to pay out-of-pocket
can access this service, considering the long waiting lists in the public sector for dialysis
treatment. Tapion Hospital’s dialysis clinic has eight dialysis stations and five dialysis
nurses (Draper, 2019). Operating hours are flexible to accommodate patients who are
employed seven days a week. The government subsidizes the cost of dialysis treatment at
Tapion Hospital for some patients to address delayed treatment and long waiting lists in
the public sector (Nurse Connie Hager, personal communication, April 15, 2019).
Problem Statement
In recent years, the worsening economy, high unemployment, and the continued
escalation of health care costs have exacerbated the financial burden for many individuals
globally (Alphonse, 2017; Tamura et al., 2018). Because employers provide most health
insurance, loss of employment is frequently accompanied by loss of health insurance and
the inability to afford health care (Garcia-Garcia & Jha, 2015; Nicoll et al., 2017). Most
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CKD patients in Saint Lucia are unemployed because of high absenteeism and frequent
comorbidities (Pan American Health Organization, 2019). The Ministry of Health has
also reported an alarming increase in the number of patients diagnosed with CKD in both
the public and private sectors (GIS, 2015; St. Lucia News Online, 2016).
According to officials from the Ministry of Health, dialysis constitutes a large part
of the Saint Lucian health care budget, contributing to the increased burden of disease to
the government. Consequently, hospitals treating CKD patients face challenges in
providing care in a resource-poor environment (St. Lucia News Online, 2019). The lack
of resources, including inadequate dialysis machines, long waiting lists, and the high cost
of medication and dialysis treatment, contribute to the decreased access to care for CKD
patients (Meade et al., 2018; St. Lucia News Online, 2016). According to the Institute for
Health Metrics and Evaluation (2016), CKD was ranked as the seventh leading cause of
death in 2005 and rose to the fifth leading cause of death in 2016 in Saint Lucia.
Similarly, CKD rose from eighth to sixth place in similar years as the leading cause of
premature death. Consequently, CKD was the leading cause of death and disability
combined in 2016 in Saint Lucia (Institute for Health Metrics and Evaluation, 2018),
making this topic critically important.
Purpose of the Study
This quantitative study's primary focus was to utilize secondary data to examine
whether a relationship exists between dialysis utilization, health insurance, and
government subsidization for CKD patients in Saint Lucia. I examined the efficacy of the
government’s subsidization program for dialysis and CKD's baseline characteristics in
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Saint Lucia. The study's covariates were age, race, gender, geographical location, CKD
stage, and attending hospital.
Research Questions and Hypotheses
RQ1: Is there a relationship between health insurance and dialysis utilization for
CKD patients when controlling for age, race, gender, geographical location, employment
status, CKD stage, CKD cause, and attending hospital in Saint Lucia?
H01: There is no statistically significant relationship between health insurance and
dialysis utilization for CKD patients when controlling for age, race, gender,
geographical location, employment status, CKD stage, CKD cause, and attending
hospital in Saint. Lucia.
Ha1: There is a statistically significant relationship between health insurance and
dialysis utilization for CKD patients when controlling for age, race, gender,
geographical location, employment status, CKD stage, CKD cause, and attending
hospital in Saint. Lucia.
RQ2: Is there a relationship between employment and dialysis utilization for CKD
patients when controlling for age, race, gender, geographical location, CKD stage, and
attending hospital in Saint. Lucia?
H02: There is no statistically significant relationship between employment and
dialysis utilization for CKD patients when controlling for age, race, gender,
geographical location, CKD stage, CKD cause, and attending hospital in Saint.
Lucia.
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Ha2: There is a statistically significant relationship between employment and
dialysis utilization for CKD patients when controlling for age, race, gender,
geographical location, CKD stage, CKD cause, and attending hospital in Saint.
Lucia.
RQ3: Is there a relationship between government subsidization and dialysis
utilization for CKD patients in Saint Lucia?
H03: There is no statistically significant relationship between government
subsidization and dialysis utilization for CKD patients in Saint Lucia.
Ha3: There is a statistically significant relationship between government
subsidization and dialysis utilization for CKD patients in Saint Lucia.
Theoretical Framework
This study's theoretical framework was grounded in Andersen and Newman's
(1995) health services utilization framework. This framework is a conceptual model
aimed at demonstrating the factors that lead to health services usage. This framework’s
primary premise is that an individual’s access to and use of health services is a direct
function of three characteristics, including (1) predisposing factors, (2) enabling factors,
and (3) need factors (Norton & Eggers, 2020). According to Andersen (1995), utilization
of health services should be examined within the context of (1) Predisposing factors such
as socio-cultural characteristics that exist before illness, (2) Enabling factors that address
the logistical aspects of obtaining care, and (3) Need elements generated by functional
and health problems of an individual.
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This framework may help to grasp an understanding of why CKD treatment is
lapsing within the Caribbean. Erickson et al. (2018) used this framework to examine
enabling factors such as employment among patients utilizing dialysis in the United
States. In another study, Perez et al. (2018) utilized this framework to test the hypothesis
that the enabling factor, health insurance, influenced the use of peritoneal dialysis in the
United States. Soyibo et al. (2011) used this framework to examine healthcare utilization
trends among CKD and ESRD patients from the Caribbean renal registry. Pallayova et al.
(2018) used this framework to explore the factors contributing to limited access to
medical services, specialist care, diagnostic tests, and medications for CKD patients in
LMICs. This study will examine the relationship between predisposing factors such as
age and race and enabling factors, such as health insurance, employment, and
subsidization, on dialysis utilization.
Nature of the Study
This study was quantitative and correlational. Data from the Ministry of Health’s
renal registry database was used in this retrospective cohort study to examine the
relationship between independent variables; health insurance, employment, and
subsidization, and CKD patients' dialysis utilization as the dependent variable. The
relationship between insured/uninsured, employed/unemployed and subsidized and
unsubsidized, and dialysis utilization are discussed. Other characteristics of the study
population, such as age, gender, race, CKD stage, geographical location, CKD cause, and
attending hospital, were examined.
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Literature Search Strategy
The search strategy used for this literature review involved electronic research
databases such as MEDLINE, CINAHL, ScienceDirect, and PubMed. The main
keywords for this study related to the topic and Boolean operators to find relevant
literature. The search keywords included chronic kidney disease, dialysis utilization,
renal disease, CKD in the Caribbean, ESRD in the Caribbean, subsidization, low-tomiddle-income countries, and end-stage-renal disease. Scholarly peer-reviewed journals
from 2016 to 2020 were included in this study. The articles' reference list was scanned in
the literature search to identify additional studies within the publication date range.
Literature Review Related to Key Variables and Concepts
This literature review includes studies on health insurance and government
subsidization programs and their impact on CKD patients' dialysis utilization. The health
services utilization model was the theoretical framework guiding this study (Norton &
Eggers, 2020). The effect of this model's components (particularly predisposing factors)
on dialysis utilization among CKD patients were examined. This literature review
highlights scholarly literature pertinent to CKD in LMICs, dialysis utilization within the
CKD population, health insurance impact on dialysis utilization, and subsidization impact
on Saint Lucia's dialysis utilization.
Chronic Kidney Disease in Low-to Middle-Income Countries
Numerous studies dealing with CKD's implications describe the condition as a
critical public health problem (Jager & Fraser, 2017). Consequently, general populationbased studies, the CKD prognosis consortium, and renal registries worldwide have
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contributed to the description of CKD's scale as a significant public health problem
(Thomas, 2019; George et al., 2017). The burden of CKD is increasing due to higher
morbidity and mortality, especially in countries, regions, communities, and ethnicities
with a higher-than-average CKD incidence (Lin et al., 2019; George et al., 2017).
Pallayova et al. (2018) also supported this fact, stating that an increase in the global
population and improvements in cardiovascular survival and aging have led to profound
global epidemiological changes. However, CKD's prevalence, clinical, and economic
burden has risen worldwide, particularly in LMICs. Although the global burden of CKD
is primarily due to diabetes and hypertension, current studies purport that other
contributing factors include limited access to health care, insufficient availability of renal
replacement therapy, and a shortage of trained personnel (Obrador & Levin, 2019).
Pallayova et al. (2018) found that LMICs have the fastest CKD growth due to limited
access to medical services, such as dialysis treatment, specialist care, diagnostic tests, and
medication. Osman et al. (2019) also suggest that LMICs have a more significant burden
in managing CKD due to limited programs and surveillance systems.
The global disease burden of CKD was assessed in a recent report evaluating the
2017 Global Burden of Disease Study results. This study revealed that certain world
regions, such as the Caribbean, reported higher CKD rates than other developed world
regions, decreasing prevalence and mortality (Thomas, 2019). Stanifer et al. (2016) argue
that countries that adopted the World Health Organization (WHO) 2015 people-centered
health services framework contributed to CKD management improvements. The peoplecentered health services framework, especially for the CKD population, emphasizes
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health care that “adopts individuals, carers, families, and communities into trusted health
systems” (Morton & Sellars, 2019). This adoption also sparked a movement among
international policymakers, service providers, and professional disciplines to strive
toward providing, at a reduced cost, all elements along the continuum of care for CKD
patients. Conversely, countries that failed to adopt this framework purported to struggle
significantly with improvement initiatives in addressing CKD's critical issue in the 21st
century.
Saint Lucia has made progress toward the adoption of the WHO’s 2017 personcentered framework. However, due to heavy reliance on international funding for health
care, CKD initiatives fall short of meeting the increasing demands (GIS, 2016; Ministry
of Health, 2019). Studies have shown that LMICs have a fragmented health system, and
CKD is not a significant priority (Crews et al., 2017; Hill et al., 2016; National Institute
of Diabetes and Digestive and Kidney Disease, 2019). Additionally, Stanifer et al. (2016)
purport that factors such as lack of data, few studies, variable quality in reporting, and
inconsistent methods for assessing and defining kidney dysfunction contribute
significantly to discovering accurate trends of CKD in LMICs.
Management of Chronic Kidney Disease in Saint Lucia
A significant number of patients suffer from CKD in Saint Lucia. In Saint Lucia,
CKD patients access dialysis treatment from either the public or the private sectors.
According to Chief Nephrologist Dr. Merle Clarke, treatment is costly, particularly for
patients at stage five requiring dialysis or a renal transplant (Ministry of Health, 2019).
CKD patients can obtain an unofficial diagnosis from any of the island's wellness centers,
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polyclinics, or hospitals. However, a nephrologist officially diagnoses patients with CKD
and determines a treatment plan. If dialysis is required, patients are free to access dialysis
at any of the public or private clinics (Government of Saint Lucia, 2018). Upon official
diagnosis, patients' data is entered into the renal registry database (Ministry of Health,
2019).
The CKD numbers are rising each year in St. Lucia. In 2015, 101 patients were on
dialysis at Victoria Hospital and St. Jude Hospital, with a waiting list of 86 patients
(Government of Saint Lucia, 2015; Ministry of Health, 2019). Data further indicated that
among those documented with ESKD, 172 had progressed to stage three and 150 to stage
four (Caribbean Renal Registry, 2018). For the average patient, dialysis treatment is out
of reach without massive government subsidization of health insurance coverage
subsidies. Dialysis subsidization does not include medication cost, which remains the
patient's sole responsibility (GIS, 2015). As CKD's prevalence and incidence continue to
rise, Saint Lucia's government turns to other countries, organizations, or financial
institutions to assist in purchasing additional dialysis machines or covering patients'
treatment through the established subsidization program (GIS, 2015).
Dialysis Utilization
Survival for individuals living with CKD depends on either a kidney transplant or
renal replacement therapy (RRT) to substitute failed kidney function (Draper, 2019).
Kidney transplantation is the transplant of a kidney into a patient with ESRD.
Hemodialysis is the substitution of the kidneys function by a specialized machine called a
dialyzer to purify the blood (Thomas, 2019). RRT is not available in all Caribbean
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countries, and where available, the most common modality is Hemodialysis [HD] (Meade
et al., 2018). Liyanage et al. (2015), in a study examining universal access to dialysis
treatment for CKD, found that in 2010, 2.618 million people received RRT. An estimated
4.902 million were reported in need of dialysis, and 2.284 million were estimated in their
conservative model to be prone to premature death due to having no access to treatment
(Liyanage et al., 2015; Luyckx et al., 2018). The rate of patients receiving dialysis is
growing at an annual global average rate of 7%, due in part to the universal aging of
populations (Mushi et al., 2015). Despite the high estimates (2 million) of CKD patients
receiving dialysis in 2010, that figure was predicted to double by 2030 (Luyckx et al.,
2017). CKD/ESRD was reported to be at an alarming growth rate of 1.3%, five times the
world’s population growth (Thomas, 2019). In 2008, approximately 1.75 million patients
worldwide received regular renal replacement therapy in the form of dialysis. 1.55
million or 89% were on hemodialysis (HD), and about 197,000 (11%) were on peritoneal
dialysis (PD). Interestingly, 62% of CKD patients were treated in LMICs.
Since 2013, the federal government assumed some or all financial responsibility
for services rendered to nearly 450,000 Americans on dialysis (United States Renal Data
System [USRDS], 2015). More recently, the CDC (2019) reported an estimated 37
million American adults diagnosed with CKD. Wu et al. (2017) assessed CKD care
quality and its association with long-term dialysis, acute kidney injury (AKI), and death.
A retrospective cohort study of 63, 260 adults with incident CKD, were enrolled in a
Longitudinal Cohort of Diabetes study. Their findings revealed 1,471 patients
commenced long-term dialysis treatment, 2,739 patients were hospitalized due to AKI,
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and 4,407 patients in the study died. Consequently, higher overall quality scores for CKD
patients were associated with lower hazard long-term dialysis treatment (Mushi et al.,
2015). Despite the quality outcomes of dialysis, Lin et al. (2019) purported that CKD
patients had higher healthcare utilization rates, morbidity, and mortality in a study that
examined the relationship between maintenance HD and emergency utilization.
Shaikh et al. (2018) also substantiated this claim in a study assessing utilization,
costs, and outcomes for patients receiving publicly funded HD. Moreover, their research
revealed that India's number of dialysis centers increased from 50 in 2008-2009 to 89 in
2011-2012. There was an estimated 29.5 percent of the population on HD in 2008 and
69.8 percent of the population in 2012. This study suggested that CKD patients absorbed
a more substantial healthcare services portion, mainly because the health system cannot
meet dialysis demands. The number of dialysis units for every 100 patients with CKD
was 0 to 1.89 across all districts in Andhra Pradesh, India, and that there was one dialysis
unit for every 100 CKD patients. Like India, Saint Lucia is considered a developing
country or an LMIC with similar constraints and limited resources. Another study
investigated dialysis provision and the implications of health economics in Malaysia.
Studies also purport that inequality in access to dialysis exists within geographical
locations in LMICs (Andersen, 2018; Mohd et al., 2017; George, Mogueo, Okpechi,
Echouffo-Tcheugui & Kengne, 2017).
Mohd et al. (2017) found that CKD's prevalence increased from 504 per million
in 2005 to 1155 per million in 2014. An estimated 1046 patients were on HD and 109 on
PD in 2014. This study also revealed inequality in access to dialysis within geographical
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regions in Malaysia, despite government funding. From these studies, it is evident that
CKD's prevalence and incidence continue to rise, especially among LMICs. Additionally,
LMICs continue to struggle with meeting the health demands of CKD patients in need of
RRT, such as HD (George et al., 2017).
Costs of Dialysis Treatment
According to Li et al. (2019), CKD and dialysis are medical and economic
problems. RRT consumes many resources as equipment and materials are expensive
(Mohd et al., 2017; Hill et al., 2016; Kramer et al., 2018). Consequently, dialysis requires
qualified personnel. Cost is defined as “the monetary value of the resource consumption
for producing a commodity or service, frequently expressed as a composite sum of
quantities of some activity multiplied by their respective prices” (Mushi et al., 2015).
There are four cost categories: “direct medical costs, direct non-medical costs, indirect
costs, and intangible costs” (p.160). Direct medical costs of dialysis include “staffing
costs, physician fees or salary, cost of dialyzers and tubing in hemodialysis, the cost
associated with radiology, laboratory and medications, capital costs of HD machines,
costs of hospitalizations and costs of out-patient consultations from other specialists
(Mushi et al., 2015). Direct non-medical costs include building costs, facility utilities, and
other overhead costs. Intangible costs are costs associated with pain, suffering, and
impairment in quality of life”(p.162). In the Caribbean region, most, if not all, countries
cannot sustain the financial burden of CKD. Shechter et al. (2017) investigated the timing
of vascular access (VA) referral for patients with CKD in need of hemodialysis (HD),
concerning age and costs. This study revealed that the cost-effectiveness of VA referral
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was primarily driven by HD's annual expenses, erythropoietin costs, and access-specific
utilities.
The increasing number of dialysis units through-out the English-speaking
Caribbean has doubled between 2006 and 2011, placing an increased financial strain on
these governments and health systems. However, issues such as limited personnel in
managing these units, lack of financial resources, and support from both the government
and private sector continue to affect the availability of these treatments in the Caribbean.
Saint Lucia continues to battle the increasing numbers of CKD patients needing RRT,
and as such, has expanded the public dialysis clinic’s capacity to accommodate more
patients (GIS, 2015). According to the Ministry of Health, the primary barrier to CKD
management's improvement efforts is the economic constraints (Government of Saint
Lucia, 2015). Saint Lucia has adopted a public-private financing model for HD, where
patients receive funding for treatment at both public and private clinics. Dr. Merle Clarke
(2019) stated that the allocation of healthcare funds in the budget falls short of meeting
the growing demand for HD, personnel, and unit maintenance. Moreover, she lamented
that CKD's poor management in a resourced poor healthcare system was consequential to
the limited funding (Ministry of Health, 2019).
In the English-speaking Caribbean and other LMICs, healthcare has become one
of the most significant financial burdens on the government (Jager & Fraser, 2017). The
government adopted various models of care, improvement initiatives, and subsidization
programs to address this burden. For example, Malaysia, an LMIC, established an HD
subsidization program in 2008 to provide treatment to CKD patients. Like Saint Lucia,
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the government adopted a public-private financing model to cover HD's cost through a
national insurance scheme (Mohd et al., 2017). Dialysis costs in Barbados were
approximately USD 156.64 per treatment in the first year and USD 145.55 in subsequent
years (Labonté et al., 2017). A total cost per patient per year of USD 18,327.22 in the
first year of HD was found, including surgical setup, and USD 17,029.54 for subsequent
years and the direct costs of HD contributed overall was 80.7% (Caribbean Renal
Registry, 2018). These findings presented data that sparked health officials' attention and
encouraged CKD patients' development funding programs.
Employment and Dialysis Utilization
Employment for CKD patients on dialysis has recently become an essential
outcome in kidney management (Liyanage et al., 2015; CDC, 2019; Draper, 2019). Longterm dialysis therapy takes a heavy toll on the quality of life for CKD patients. Fatigue,
decreased physical capability, impaired social and mental functioning all contribute to
this forlorn state. CKD patients experience tremendous difficulty maintaining dialysis
treatment while keeping regular employment (Erickson et al., 2018; Luyckx et al., 2017).
Lakshmi (2017), in a cross-sectional study of employment and dialysis utilization in
South India, found that patients' employment status before dialysis was 60% (93 out of
155) for patients receiving HD. The study revealed that 44% (41 out of 93) experienced a
loss of employment status after initiation. Chironda and Bhengu (2019) also agreed that
long-term dialysis affected employment status. Another study explored barriers to CKD
management in renal clinics in KwaZulu – Natal Province, South Africa. The researchers
examined the side effects of treatment, the longevity of hemodialysis treatment, lack of
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employment opportunities resulting from CKD, and health insurance coverage. All
barriers to the management of CKD. Despite current measures by state hospitals to
provide CKD management, barriers to the management of CKD still exist.
Harris (2017) examined the issue of ESKD in a study that included 92 participants
from around the globe, including 16 participants from 11 LMICs. This study found that
LMIC countries were severely affected by the lack of resources and finances to manage
CKD, particularly with a loss of employment for long-term dialysis patients. The study
further purported that LMICs would benefit from improved workforce training, equitable,
efficient, and cost-effective funding models, among others, in the management of CKD.
Coming a little closer to home, Meade et al. (2018) examined the causes of CKD and its
association with high morbidity and mortality at two hospitals in Antigua. A retrospective
review of CKD patients' medical records diagnosed between January 1, 2005, and
December 1, 2013, was performed. The results revealed that CKD causes were diabetes
mellitus, hypertension, glomerulonephritis, and lupus nephritis.
Consequently, most of the CKD patients in the study faced difficulty keeping
employment, and thus, the financial burden fell upon their families and the government.
Early recognition and aggressive CKD management significantly reduced the clinical and
economic burden (Meade et al., 2018). In Saint Lucia, most CKD patients are
unemployed and reliant on their families and the government for financial assistance
(Government Information System, 2015; Ministry of Health, 2019). Furthermore, HD and
the medications usually prescribed to CKD patients are not affordable for the average
patient. Dialysis is an intensive and time-consuming treatment. Patients on dialysis may
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have other medical problems, including cardiovascular disease, diabetes, bone disorders,
anemia, visual impairment, malnutrition, depression, and cognition changes. These
factors are often associated with job loss (Jager & Fraser, 2017).
The Ministry of Health embarked on numerous initiatives, especially at the
primary level, to curb CKD's growing prevalence in Saint Lucia (GIS, 2016). The
negative consequences of CKD are evident at both the social and economic levels.
Improvement efforts in CKD management resulted in expanding dialysis accessibility
(Government of Saint Lucia, 2018). Okpechi, Bello, Ameh, and Swanepoel (2017)
examined appropriate approaches to manage CKD in LMICs. Their study revealed that
workforce deficiencies, infrastructure, cost of treatment, lack of proper systems approach
policies were barriers to effective CKD care delivery in LMICs. Additionally, they
concluded that the adoption of WHO proposed Innovative Care for Chronic Conditions
(ICCC) was presented as a suitable health system model to help manage CKD's
increasing incidence in LMICs.
Health Insurance, Subsidization, and Dialysis Utilization
According to Luyckx et al. (2017), access to dialysis remains highly inequitable in
LMICs despite dialysis facilities' existence. To address CKD's growing prevalence and its
financial impact on Saint Lucia, the government launched a dialysis subsidization
program in 1999 (Government Information System, 2016; Ministry of Health, 2019).
Consequently, this subsidization program helps cover some of the cost of care for patients
with no medical insurance coverage, unemployed, or disabled due to CKD (Ministry of
Health, 2019). Like Saint Lucia, many countries take the lead from the United States,
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where the government intervenes in providing support for vulnerable patients on dialysis
(Ajmal et al., 2019). Some individuals purchase private health insurance covering some,
if not all, of their dialysis treatments, labs, and medications. However, this is not the
norm, as most CKD patients obtain health insurance coverage through their employment
(GIS, 2016). Saint Lucia is far from reaching the financial support level that countries
like the United States make toward CKD management (Caribbean Renal Registry, 2018).
In 1972, the United States Congress established Medicare coverage for ESRD patients,
despite age or high treatment costs (USRDS, 2015). These initiatives have contributed
significantly to the improvement of the management of CKD. According to Andersen
(2018), the impact of Medicare's expansion among individuals with CKD has increased
coverage by 30% and increased doctor visits by 35%.
Additionally, this expansion decreased mortality due to CKD in the under 65
population between 0.5, 50, 1.0 deaths per 100,000 (Andersen, 2018). Perez et al. (2018)
examined the effect of health insurance on dialysis utilization using a retrospective cohort
analysis of patients with similar socioeconomic status, and limited insurance coverage
was included in the study. This study found that patients with limited insurance had an
absolute lower probability of dialysis use. Ajmal et al. (2019) corroborated these findings
and found that improvement initiatives by the Centers for Medicare and Medicaid
Services (CMS) revealed improved outcomes for CKD patients. Many countries are
adopting programs that improve access to care for CKD patients. Before 2016, CKD was
managed locally by internal medicine physicians. Since then, the island now has two
nephrologists (GIS, 2016). For example, through the Department of Medicine’s rigorous
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efforts at the University of the West Indies, Jamaica has nine adult and two pediatric
nephrologists (Horspool, 2018). The Caribbean Institute of Nephrology (2018), aside
from conducting programs and forums to educate the public, also extend training to
health professionals in neighboring islands. Many Caribbean countries subsidize a large
extent of health care for CKD patients (Caribbean Renal Registry, 2018; George et al.,
2017). Tourism generates an extensive amount of revenue for Caribbean Countries.
Countries like Barbados, Jamaica, Cayman Islands, Trinidad, Tobago, and Saint Lucia
offer dialysis for tourists traveling. Dialysis availability and accessibility are essential
factors in the sustainability of the tourism industry.
According to Dr. Merle Clarke, government subsidization does not cover all the
costs associated with CKD patients' health expenses. Patients assume responsibility for
out-of-pocket costs, including weekly dialysis treatments, not subsidized, laboratory
testing, and medication. Patients can receive coverage for dialysis through the
subsidization program, anywhere from one to three treatment sessions a week.
Additionally, for patients who have no health insurance coverage or are not recipients of
a subsidization program, dialysis becomes tremendously inaccessible (Luyckx et al.,
2017). Krishnan (2019) argues that government subsidization provides a substantial
benefit to CKD patients who have limited income and must cover part of treatment costs
and other ancillary expenses, such as transportation to and from treatments and
medications. Jager and Fraser (2017) purport that in countries like India, where much of
the payment for dialysis is out-of-pocket, subsidies could significantly impact CKD
patients. There are substantial differences in how various governments provide and
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subsidize disability and unemployment benefits to those affected by CKD. As the world’s
population increases, so will societal demands for health equity. Morton and Sellars
(2019) suggest that balancing societal and personal costs for CKD will be a continuous
learning curve for policymakers, health leaders, communities, families, and patients.
This literature review presents the global trends, management, costs, employment,
subsidization, and dialysis utilization for CKD in the Caribbean and other LMICs.
Definitions
Chronic kidney disease (CKD): A progressive loss of renal function that lasts for
more than three months and is classified according to the degree of kidney damage
measured by the level of proteinuria and the decline in glomerular filtration rate (GFR;
NKF, 2019).
Dialysis: The clinical purification of blood as a substitute for the normal function
of the kidney. The two main types of dialysis are peritoneal dialysis and hemodialysis.
Peritoneal dialysis entails placing a soft, hollow tube into the lower abdomen near the
navel and a particular dialysate solution into the peritoneal cavity (Draper, 2019). The
dialysate left in the stomach for a period absorbs waste products and toxins through the
peritoneum. Fluid drained from the abdomen is measured and discarded (Vadakedath &
Kandi, 2017). Hemodialysis is a procedure where a dialysis machine and a special filter
called an artificial kidney, or a dialyzer, are used to clean the blood. The process entails
an arteriovenous fistula access in the arm, and the joining of an artery and a vein for
blood purification (National Kidney Foundation, 2019). As shown in Figure 2, a
hemodialysis machine connected to the arteriovenous access in the arm of a patient drains
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the blood and bathes it in a particular dialysate solution to remove waste substances,
fluid, and toxins, and then returns it into the bloodstream (National Institute of Diabetes
and Digestive and Kidney Diseases, 2019).
Dialysis utilization: The measure of CKD patients’ use of dialysis treatment to
manage their condition.

Figure 2
Diagrammatic Representation of a Dialyzer

Note. This figure presents a diagrammatic representation of a dialyzer, depicting the
dialysis process. From Hemodialysis, by the National Institute of Diabetes and Digestive
and Kidney Disease, 2018 (https://www.niddk.nih.gov/health-information/kidneydisease/kidney-failure/hemodialysis). In the public domain.

Employment: The relationship between the employer and employee based on a
contractual agreement for paid work.
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End-stage renal disease: An irreversible decline in a person’s kidney function that
is severe enough to be fatal in the absence of dialysis or kidney transplantation (Benjamin
& Lappin, 2020).
Health care utilization: The quantification or description of the use of services by
persons to prevent and cure health problems, maintain health and well-being, or obtain
information about one's health status and prognosis (Encyclopedia of Behavioral
Medicine, 2019).
Health insurance: Coverage that provides payments of benefits in whole or in part
for an individual's risk of incurring medical expenses (Perez et al., 2018).
Kidney transplant: A healthy kidney's surgical placement into the body from a
deceased donor or a close living relative. A kidney transplant is a treatment, not a cure,
and requires antirejection and other medications to maintain the transplant (NKF, 2019).
Ministry of Health: The government body set up by the central government of Saint Lucia
and mandated with the health sector's stewardship and leadership. This ministry is responsible for
providing “quality care to individuals, families, and communities regardless of race, religion,
socioeconomic status or political affiliation” (Ministry of Health, 2019, Mission section).
Pan American Health Organization (PAHO): An entity that proclaims itself as “the
world’s oldest international public health agency” and which engages in “strategic collaborative
efforts among the Member States and other partners to promote equity in health, to combat
disease, and to improve quality of life of the peoples of the Americas” (PAHO, 2017, para. 1).

Renal replacement therapy (RRT): Therapy that replaces the normal bloodfiltering function of the kidneys due to kidney failure; it includes hemodialysis, peritoneal
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dialysis, and kidney transplantation, which is the ultimate form of replacement of the old
kidneys (National Institute of Diabetes and Digestive and Kidney Disease , 2019).
Assumptions
There were several assumptions for this study. The first assumption was that the
existing National Renal Registry cohort data contains accurate and reliable information.
This assumption was essential because retrospective cohort data may involve selection
bias and misclassification bias (Back & Kelly, 2019). An examination of patients with
CKD who accessed dialysis treatment from 2015 to 2019 in Saint Lucia was carried out
to limit misclassification bias. Cohort data from the national renal registry of the
Ministry of Health, central statistics office, was used in this study. The central statistics
office is responsible for internal automated and external quality control scrutiny to ensure
that databases are accurate and beneficial to researchers, practitioners, and policymakers.
The second assumption was that the existing database would contain all the
variables needed for this study. Heinze et al. (2018) highly recommend that researchers
use variables from the same dataset to avoid reliability issues. The third assumption was
that the data set variables would be valid and appropriate for measuring the conceptual
framework domains. Shang et al. (2018) purported that data suitability and quality are
essential to a successful study. Furthermore, they suggest that a dataset's fitness is
determined by the extent to which it meets the research purpose or needs. Finally, the
assumption that the simple random sampling procedure is accurate and truthful eliminates
potential internal and external validity threats. According to Back and Kelly (2019),
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stratified random sampling allows the opportunity to obtain a sample population that best
represents the entire population studied.
Scope and Delimitations
To answer the RQs and address the research gap, this study was delimited to a
national sample of CKD patients who accessed dialysis for five years from 2015 to 2019.
Additionally, it was delimited to only hemodialysis utilization. All other forms of RRTs
were excluded. Therefore, the sample selected may not represent all patients in the
national CKD population who utilized dialysis and received government subsidies. Due
to this delimitation, the study's findings had limited external validity and were not
generalizable to other CKD patients outside Saint Lucia.
A significant strength of this study was the use of a National Dataset. Access to
this dataset provided the opportunity to use CKD information, dialysis utilization, and
sufficient numbers of males and females in the CKD population for meaningful analysis.
According to Frankfort-Nachmias (2018), national datasets are seen as the intellectual
output of research and prove beneficial for longitudinal or retrospective studies.
Limitations
One limitation of this study was generalizability. This study's findings could not
be generalized to the entire CKD population in Saint Lucia because it was limited to only
those who accessed hemodialysis from 2015 to 2019. Excluded from this study were
CKD patients who received other RRTs, were non-national (visitor), or accessed
hemodialysis outside this period. Additionally, due to demographic differences in the
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study’s population, the findings may not be generalized to other CKD populations of
LMICs.
A second limitation of this study was the reliance on self-reported information,
which may be subject to misclassification, selection, and reporting bias. Data was
crossed-checked and compared with administrative data from the chief nephrologist or
dialysis clinics to address this limitation. A third limitation was that medical costs due to
comorbidities were not included in this study's primary or sensitivity analysis.
Significance
This study's quantitative findings may provide insight into the financial barriers
that affect dialysis utilization and, by extension, the management of CKD patients in
Saint Lucia. This project was unique because it was the first to examine this specific
population and address a non-communicable disease that had not been thoroughly
examined in Saint Lucia before. It may add to the limited research on CKD management
related to health delivery (Tamura et al., 2018) in LMICs. Additionally, this study may
inform government health officials, policy makers, and healthcare leaders of the efficacy
of the dialysis subsidization program for CKD patients in Saint Lucia.
This study may lead to a greater understanding of how access to dialysis treatment
has improved due to government subsidization. Information from this study may
contribute to health service delivery improvement initiatives and motivate policies that
may remedy financial barriers and improve access and quality of care for CKD patients in
Saint Lucia (Wilk et al., 2019). Consequently, the findings may provide information
about CKD trends, financial barriers to access care for CKD patients, and
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recommendations for policy or social change improvement initiatives. Furthermore, the
proposed study was essentially a policy analysis of the government subsidization
program efficacy and, therefore, potential societal relevance. If the findings reveal that
government subsidization is positively impacting dialysis utilization, then the policy
works. If it does not, this provides evidence that the policy should be revised.
Summary and Conclusions
CKD is considered a progressive disease in patients with hypertension and
diabetes that efficient primary care interventions can help (NIH, 2014). Implementing
health initiatives at the local level, such as subsidizing anti-hypertensive and diabetic
medications, facilitating lifestyle and lipid modification programs, and equipping
wellness centers and polyclinics with the necessary human resource is essential (Business
View Caribbean, 2019; National Institute of Diabetes and Digestive and Kidney Disease,
2019; Nicoll et al., 2017). Implementing measures to decrease the number of patients
who develop CKD may reduce the demands for more resources (Caribbean Renal
Registry, 2018).
Current research suggests that as the global population increases annually, so will
the number of patients who develop CKD (Jager & Fraser, 2017; Morton & Sellars, 2019;
Business View Caribbean, 2019). Investment in more equipment and health professionals
specialized in this area is essential but may not be sustainable, particularly in LMICs
where patients lack the financial resources to manage CKD (Erickson et al., 2018).
LMICs could glean from implementing government programs such as the Affordable
Care Act of 2010, which provided coverage for many uninsured CKD patients who
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needed critical care access. Making CKD a significant health priority by implementing
subsidy programs or strengthening existing ones may help alleviate its current financial
burden (Draper, 2019; Tamura et al., 2018; Anderson, 2018).
Although the CDC (2018) has stated that CKD is a global health problem, the
International Society of Nephrology (2019) further purports that CKD's prevalence and
its complications vary widely worldwide. Socha (2019) concluded that a patient’s health
insurance status affects dialysis utilization and modality choice after conducting a
retrospective cohort analysis to examine whether peritoneal dialysis was affected by
health insurance status. According to a report from the USRDS (2018), dialysis
utilization for new patients was recorded at an increased 80% due in part to Medicare
coverage and improved health awareness. A study that examined the effect of universal
insurance coverage on access to care for CKD patients, Harris and Davies (2019),
purported that inequities, as shown in Figure 3, were evident in dialysis utilization CKD
implementation of universal health coverage in LMICs. Additionally, they found that
dialysis utilization varied in different regions of the same country and between urban and
rural areas.
Stanifer et al. (2016) argue that priority is low in the public health response to
CKD among LMICs. Consequently, making CKD a priority could lead to social change
in CKD management and the reversal of its high ranking as a cause of death and
disability in Saint Lucia.
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Figure 3
Prevalence and Incidence Rates of End-Stage Renal Disease

Note. This figure presents the (a) Prevalence and (b) incidence rates of end-stage kidney
disease (ESKD) (treated), dialysis, hemodialysis, peritoneal dialysis, kidney
transplantation (Tx), and donor type in high-income countries versus non-high-income
countries (Harris & Davies, 2019).
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Section 2: Research Design and Data Collection
Introduction
The purpose of this quantitative study was to examine the relationship between
health insurance, employment, subsidization, and dialysis utilization among CKD
patients in Saint Lucia. Although there have been numerous studies on dialysis
utilization's financial barriers, few researchers have examined the efficacy of government
subsidization for dialysis utilization in LMICs (Caribbean Renal Registry, 2018; Erickson
et al., 2018; Li et al., 2019). Consequently, policymakers, healthcare officials, and other
stakeholders may obtain information that can impact CKD’s future payment models and
disease management in Saint Lucia. In this section, I discuss the research and design
rationale, methodology, and threats to validity.
Research and Design Rationale
The quantitative causal-comparative research design was used in this doctoral
study to investigate group populations. I compared same subjects (individuals diagnosed
with CKD) across the period 2015–2019, using a single data set with information on
dialysis treatment at any of the dialysis clinics on the island (Owen King European Union
Hospital, Victoria Hospital, St. Jude Hospital, and Tapion Hospital). The dependent
variable in the study was dialysis utilization. The independent variables were
subsidization, employment, and health insurance. Covariates included age, gender, race,
geographical location, CKD stage, CKD cause, and attending hospital. Secondary data
for this study were obtained from the Ministry of Health’s Central Statistics Office,
which is responsible for the collection, compilation, analysis, and dissemination of
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statistical information in Saint Lucia (Government of Saint Lucia, 2018). In this way, the
data were obtained in a manner that was feasible and accessible (Frankfort-Nachmias,
2018). Raw data from the various dialysis clinics on the island are submitted central
statistics office through the Ministry of Health for further analysis. Specifically, I
obtained data for the study from the renal registry, which records data for all CKD
patients accessing dialysis treatment in both the public and private sectors. The renal
registry was developed in response to the need of health officials, policy makers, and
health care providers to understand the prevalence of CKD and why it has become the
number one cause of death and disability combined in Saint Lucia (Caribbean Renal
Registry, 2018). This study may help bridge the gap and provide necessary information
for social change, including insight into the dialysis subsidization program's efficacy.
Specifically, I analyzed a retrospective CKD cohort using data from three dialysis
clinics in Saint Lucia that accessed care between 2015 and 2019. The quantitative causalcomparative design was chosen for four reasons. First, the quantitative methodology is
employed when the goal is to measure variables numerically using commonly accepted
measures of the physical world (Creswell, 2018; Hair et al., 2018; Leedy & Omrod,
2018). Second, the quantitative methodology is used when RQs are examined through the
statistical examination of data (Creswell & Creswell, 2018). Third, the quantitative
methodology is employed when the goal of the research is to generalize the findings to a
larger population from which the study sample is derived (Creswell, 2018; Hair et al.,
2018; Leedy & Omrod, 2018). Fourth, a quantitative study involves using a relatively
large sample size, which allows for the projection of results to the target population
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(Creswell & Creswell, 2018). The use of retrospective data helps researchers to determine
trends in health service utilization (Creswell & Creswell, 2018). Strengths of
retrospective cohort studies include maintaining a sequence of events and exploring
several outcomes, such as developing a disease over some time and risk factors of an
illness and other factors associated with disease outcomes (Creswell & Creswell, 2018;
Hsu et al., 2019).
I chose this study's design to address the gaps in research. A comparative analysis
allowed for examining the relationship between government subsidization, employment
status, and health insurance in dialysis utilization trends. Use of this research design may
advance health knowledge on the efficacy of health subsidization programs and health
insurance's impact on disease management. It may also guide policy makers and
stakeholders in selecting the best approaches in developing payment models and
implementing disease management interventions in the future in Saint Lucia and other
LMICs.
Methodology
Population
The target population comprised males and females 18 years of age and older
diagnosed with CKD in Saint Lucia and accessed dialysis treatment between 2015-2019.
Additionally, the target population included patients within the race categories of African
Descent, East Indian, or Mixed. The estimated sample size was approximately 979 CKD
patients registered in the national renal registry from 2015 to 2019. The target population
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was limited to St. Lucian residents accessing dialysis at any of the four clinics located on
the island.
Sampling and Sampling Procedures
For this study, the data analyzed were secondary data modified based on the
inclusion and exclusion criteria outlined in this section. The sampling procedures
involved collecting and organizing secondary data from the renal registry (Caribbean
Renal Registry, 2018; Government of Saint Lucia, 2018). The sampling process included
analyzing the patients diagnosed with CKD and examining the renal registry's total
population. I selected applicable data using simple random sampling.
After examining the data’s characteristics, it became clearer that simple random
sampling was a more appropriate sampling methodology, given that all patients in the
renal registry satisfied essential variables such as age, gender, and the like. According to
Depersio (2018), “simple random sampling is a method used to pull a smaller sample
from a larger population and use it to research and make generalizations about the larger
group” (p.124 ). The use of a simple random sample also allows for an equal probability
of selecting each unit within a group (Creswell & Creswell, 2018). By using specific
procedures, I examined dialysis utilization among CKD patients and compared usage
across payment methods. Additionally, logistic regression was applied to control for
covariates and compare independent variables. This study's data included descriptive
statistics using categorical data to measure and compare with crosstabulations, chi-square
analysis, frequency distributions, and counts between groups.
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Sample Size and Power Analysis
At the time of the study, 1,250 individuals were enrolled in the Central Statistics
Office’s renal registry. I further stratified this sample by using a proportional
stratification process that included using simple random stratum selection. To calculate
this study's effect size, I used both chi-square analysis and correlation analysis to measure
the effect size between groups. Using multiple methods allowed for comparisons of
dialysis utilization among the CKD population based on three factors: health insurance,
subsidization, and employment (see Faul et al., 2008). Power analysis for a linear
regression was conducted in G*Power to determine a sufficient sample size using an
alpha of 0.05, a power of 0.80, and a small effect size (f2 = 0.02) (Creswell & Creswell,
2018). Based on the assumptions, the desired sample size was 979. Lakens et al. (2018)
suggested that researchers may anchor their power analysis on the smallest effect size
with clear benchmarks if reluctant to rely on the literature.
Instrumentation and Operationalization of Constructs
Before data collection, I obtained Institutional Review Board (IRB) approval from
Walden University and the local site, the Ministry of Health. The Ministry of Health
approval was a two-step process, requiring permission from the Research Ethical
Committee (REC) of the Medical and Dental Council, and the Medical Directors of the
various hospitals. IRB approval was needed to obtain data use agreements approved for
data collection and analysis. This study posed minimal risk, primarily because it included
data from an existing cohort with no identifiers and secondary. The data file contained no
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personally identifiable information. Therefore, there was no concern for violations of
confidentiality.
Operationalization
Across the three RQs, there were three independent variables, employment, health
insurance, and subsidization, and one dependent variable, dialysis utilization. RQ1 asked,
Is there any relationship between health insurance and dialysis utilization for CKD
patients when controlling for age, race, gender, geographical location, CKD stage, and
attending hospital in Saint. Lucia. For this study, health insurance referred to any form of
insurance coverage covering dialysis treatment costs. The independent variable health
insurance was described as a binary variable (yes/no).
RQ2 asked, Is there any relationship between employment and dialysis utilization
for CKD patients, when controlling for age, race, gender, geographical location, CKD
stage, and attending hospital in Saint. Lucia? Employment was defined as any form of
paid work in which a CKD patient is actively involved. The independent variable
employment was described as a binary variable (yes/no). RQ3 asked, Is there any
relationship between government subsidization and dialysis utilization for CKD patients
in Saint Lucia? For this study, subsidization was defined as a benefit given by the
government to CKD patients, resulting in reduced dialysis treatment costs to help reduce
the economic burden on these patients. Independent variable subsidization is described as
a binary variable and assigned the following categories: 1 for subsidization and 0 for no
subsidization.
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Dialysis utilization will be described as a binary variable due to the utilization of
logistic regression analysis for this study and assessed by the long-term rate of dialysis
treatments a CKD patient received. In the binary coding process, dialysis utilization was
coded as, “1” for yes utilization, and “0” for no utilization. This study focuses on
hemodialysis because it is the only type of dialysis provided to and utilized by CKD
patients in Saint Lucia.
Data Analysis Plan
The data analysis process consisted of three phases, the data preparation phase,
the preliminary analysis phase, and the primary analysis phase. The data preparation
phase comprised the data imputation into SPSS v26 (IBM SPSS Statistics, 2019). After
that, frequency descriptive statistics were performed to evaluate any missing data or data
errors. Data errors found were fixed and kept for analysis. Data errors that could not be
fixed were removed from the data file and were not included in the study. The same was
done for missing values. Data errors and missing values were minimal in this study. After
the data was checked for errors and missing values, new variables or variable recoding
was completed at this point. The preparation phase was completed when all the data had
been recorded.
The next phase was the preliminary phase. During this phase, the tests of
parametric assumptions were conducted. A multiple logistic regression analysis was
conducted to predict a correlation between independent variables, medical insurance,
employment, government subsidization, and dependent variable, dialysis utilization while
controlling the covariates. This study's data includes descriptive statistics using
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categorical data to measure and compare crosstabulations, chi-square analysis, frequency
distributions, and counts between groups. Conducting a multivariable analysis helped
establish the relationship between the dependent and the independent variables (Creswell
& Creswell, 2018). The findings of this study may provide information about current
CKD trends. They may reduce the literature gap about government subsidization's
efficacy and the relationship between health insurance and employment on dialysis
utilization for CKD patients in Saint Lucia.
Finally, the primary analysis was conducted to address the three RQs. The binary
logistic regression analysis was performed three times. If the p-value is less than .05, then
the relationship between the dependent and independent variables in the model is
statistically significant. If the p-value is less than .05, then the odds ratios will be
reviewed to determine which independent variable makes a considerable contribution to
the model. The target populations consist of males and females 18 years and older
diagnosed with CKD in Saint Lucia throughout 2015-2019. Additionally, the target
population is limited to the race categories: African descent, East Indian, Mixed, or other.
Threats to Validity
Internal validity refers to whether the conclusions that are reached in a study are
trustworthy, meaningful, and accurate (Heinze et al., 2018; Creswell & Creswell, 2018).
One threat to internal validity is maturation. It may be that the passing of time and the
progression of their disease affects their ability to access dialysis treatment and not
financial factors. Another threat to internal validity is confounding. Confounding refers to
changes in an outcome variable that is thought to have resulted from a third variable. It
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may be that dialysis utilization may be affected by other factors such as patient health
literacy level. External validity refers to the generalizability of a study (Creswell &
Creswell, 2018).
Ethical Procedures
The data from the Renal Registry is made available for download through the
Minsity of Health. The data file contains no personally identifiable information in the
data, so there is no concern for confidentiality violations. Once the analysis was
completed and the report was written, the data was stored in a secure, password-protected
computer that was not connected to the internet. All IRB protocols were followed to
ensure no violations of ethical research standards or IRB regulations.
Summary
The purpose of this proposed quantitative causal-comparative research study was
to examine dialysis utilization based on CKD patient’s health insurance status,
government subsidization, and employment status using a retrospective cohort study
design for the five years from January 2016 to December 2019. The sample was obtained
from secondary data in an existing Ministry of Health National Renal Registry extracted
from all dialysis clinics in Saint Lucia. Descriptive analyses were performed to describe
the study population and provide the means, standard deviations, frequencies, a range of
scores, and percentages (Creswell & Creswell, 2018).
The data analysis process consisted of three phases; the data preparation phase,
the preliminary analysis phase, and the primary analysis phase. The relationship between
health insurance, subsidization, employment, and dialysis utilization was examined using
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binary logistic regression analysis to predict a correlation while controlling the
covariates. This study's data includes descriptive statistics using categorical data to
measure and compare with crosstabulations, chi-square analysis, frequency distributions,
and counts between groups. The primary analysis was conducted to address the three
RQs. The multiple linear regression analysis was performed three times. If the p-value
was less than .05, then the model as-a-whole is significant. If the p-value was less than
.05, then the odds ratios were reviewed to determine which groups significantly
contributed to the model.
Due to limited research on the efficacy of government subsidization for dialysis
in Saint Lucia, this study was geared toward providing information on the relationship
between subsidization and dialysis utilization and insight into future payment models and
disease management initiatives. Furthermore, the study findings may provide insight into
the financial barriers that affect dialysis utilization in the management of CKD and, thus,
contribute to health service delivery improvement initiatives to remedy these barriers and
improve access and quality of care for CKD patients in Saint Lucia.
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Section 3: Presentation of the Results and Findings
Introduction
The study's purpose was to determine if a relationship existed between health
insurance, employment, subsidization, and dialysis utilization among CKD patients in
Saint Lucia. It sought to gain information about the government subsidization program's
efficacy for dialysis treatment. This study was the first examination of CKD
characteristics in the population of Saint Lucia. The following RQs were addressed
through various statistical analyses:
RQ1: Is there a relationship between health insurance and dialysis utilization for
CKD patients, when controlling for age, race, gender, geographical location, CKD stage,
and attending hospital in Saint. Lucia?
H01: There is no statistically significant relationship between health insurance and
dialysis utilization for CKD patients when controlling for age, race, gender,
geographical location, CKD stage, and attending hospital in Saint. Lucia.
Ha1: There is a statistically significant relationship between health insurance and
dialysis utilization for CKD patients when controlling for age, race, gender,
geographical location, CKD stage, and attending hospital in Saint. Lucia.
RQ2: Is there a relationship between employment and dialysis utilization for CKD
patients when controlling for age, race, gender, geographical location, CKD stage, and
attending hospital in Saint. Lucia?
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H02: There is no statistically significant relationship between employment and
dialysis utilization for CKD patients when controlling for age, race, gender,
geographical location, CKD stage, and attending hospital in Saint. Lucia.
Ha2: There is a statistically significant relationship between employment and
dialysis utilization for CKD patients when controlling for age, race, gender,
geographical location, CKD stage, and attending hospital in St. Lucia.
RQ3: Is there a relationship between government subsidization and dialysis
utilization for CKD patients in Saint Lucia?
H03: There is no statistically significant relationship between government
subsidization and dialysis utilization for CKD patients in Saint Lucia.
Ha3: There is a statistically significant relationship between government
subsidization and dialysis utilization for CKD patients in Saint Lucia.
In this section, I describe the secondary data set and the analyses used to address
the RQs. The statistical analyses, crosstabulations, chi-square analysis, frequency
distributions, counts between groups, and statistical hypothesis testing are presented. I
discuss whether the results are statistically significant and whether the null hypotheses
were rejected or failed to be rejected.
Data Collection of Secondary Data Set
I obtained secondary deidentified data from the Ministry of Health renal registry.
Raw data are collected by the Ministry of Health from all dialysis clinics at the various
hospitals through the Central Statistics Office. These data are updated periodically. The
Central Statistics Office required time to update the data and have it coded to maintain
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confidentiality before handing it over for processing. Despite obtaining official IRB
approval from the Ministry of Health and Walden University, I had to seek additional
authorization from each hospital to use their data for research purposes per the research
ethics protocols for Saint Lucia. Therefore, before the data set was released, I contacted
each hospital and provided key staff with a copy of IRB approvals. Once I obtained final
approvals, the data set was then released for analysis. A password-protected Microsoft
Excel file containing the data set was submitted electronically to me, including all the
required variables for analyses.
The sample included 979 CKD patients belonging to one of three hospitals on the
island: Tapion Hospital, Owen King European Union Hospital, and St. Jude Hospital.
Patients in the sample were placed into three race categories: African, West Indian, and
Mixed. They were coded into one of 10 district categories: Anse La Raye, Canaries,
Castries, Choiseul, Dennery, Gros Islet, Laborie, Micoud, Soufriere, and Vieux Fort. The
sample represented patients diagnosed with CKD registered in the renal registry and
accessed dialysis treatment for 2015–2019. This study sought to determine whether there
was a relationship between employment, insurance, subsidization, and dialysis utilization
and assess the government subsidization program's efficacy for CKD patients requiring
dialysis. The sample population included in the data set was appropriate for this study.
Data Analysis
I undertook a preliminary coding exercise for each of the variables to facilitate
data processing in IBM-SPSS Statistics Version 26.0. The data were thoroughly reviewed
and checked at the case and variable level for consistency to ensure successful
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importation into IBM-SPSS Statistics Version 26.0 and eventual interpretation of the
results. Additionally, data adjustments were made using Microsoft Excel before
transferring it into SPSS. I implemented various values coding and parameter settings for
each variable.
The first procedure performed in IBM-SPSS Statistics Version 26.0 was running
the frequency tables for each variable to report on basic descriptive statistics that would
help understand each variable and the dataset by extension. Most importantly, the
frequency tables reported zero missing cases. This indicated that the data entry process
was successful and that the data was ready for further analysis. The second procedure
performed in IBM-SPSS Statistics Version 26.0 was the generation of crosstabs for
relevant variables such as
•

dialysis utilization and insurance

•

dialysis utilization and employment

•

dialysis utilization and subsidization

•

dialysis utilization and gender

•

dialysis utilization and race

•

dialysis utilization and district

•

district and gender

•

hospital and subsidization

The third procedure performed in SPSS before running the multiple logistic
regression analysis checked for multicollinearity between independent variables to ensure
that the regression analysis would be valid. I present these results and conclusions in the
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section on correlation and multicollinearity. The fourth procedure was multiple logistic
regression analysis between the dependent variable (dialysis utilization). It combined
independent variables (insurance, employment, and subsidization) to determine whether a
relationship/dependence between these variables existed. The statistics applied were
Pearson’s chi-square test to determine statistical significance between variables. Cox &
Snell R Square and Nagelkerke R Square were employed to assess the strength of the
independent variables' impact on the dependent variable. The interpretation of results will
be addressed later on in this section.
Ultimately, I performed separate chi-square tests for each independent variable
against the dependent variable to determine whether there was any
relationship/dependence between them separately and respond to each RQ and testrelated hypotheses. Statistics applied to measure the strength of the association were eta
statistic, and phi-Cramer’s V. The results and interpretations are presented later on in this
section.
Results
Frequency tables for each variable are presented to report on basic descriptive
statistics that would help understand each variable and the dataset by extension. This is
important to this study because it is the first time this population was investigated in Saint
Lucia. As shown in Table 1, the sample comprised 979 CKD patients. Covariates for this
study included age, race, geographical location or district, CKD stage, CKD Cause, and
attending hospital. Given that this study is the first to provide descriptive statistics about
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the CKD population in Saint Lucia, I examined the frequencies for this population across
the variables.

Table 1
Frequency Table: General Statistics of CKD Population
Covariate
Statistic
N (valid)
Missing
Mode
Range
Minimum
Maximum

Gender

Race

District

CKD
stage

979
0
2
1
1
2

979
0
1
2
1
3

979
0
3
10
1
11

979
0
5
4
1
5

Hospital

Cause of
CKDcoded

979
0
2
2
1
3

979
0
1
7
1
8

As shown in Table 2, the CKD population in this study comprised 470 males and
509 females, representing a ratio of 0.48:0.52, male to female. According to the Institute
for Health Metrics and Evaluation (2020), Saint Lucia’s population is 182,790, with the
male population is 90,019 and the female population is 92,771. Given the country’s
gender demographic, it is essential to note that the CKD population mirrors that
distribution, where more females make up the CKD population.
Table 2
Frequency Table: Gender of CKD Population
Gender

Male
Female
Total

Frequency

Percent

Valid
Percent

Cumulative
Percent

470
509
979

48
52
100

48
52
100

48
100
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Saint Lucia’s population is predominantly of African Descent/black (85.3% of the
total population), followed by mixed African-European or mixed African- India descent
(11% of the total population), then West Indian (2.2% of the total population) and white
(0.6% of the total population). For this study, the CKD population fell within 1 of 3
ethnic groups (African Descent, West Indian, and mixed). Since there were no
individuals of white descent in the dataset, this category was omitted during the coding
and analysis process. As shown in Table 3, the largest CKD population consists of 93.3
% African Descent (913 of the total CKD population). 4.4% of the CKD population were
West Indian (43 of the total CKD population), and 2.3% of the CKD population were
mixed (23 of the total CKD population).
Table 3
Frequency Table: Race of CKD Population
Frequency
African Descent
West Indian
Mix
Total

913
43
23
979

Race
Percent
93.3
4.4
2.3
100

Valid Percent

Cumulative Percent

93.3
4.4
2.3
100

93.3
97.7
100

As shown in Table 4, the median age of this sample population was 65 years. The
minimum and maximum ages were 20 and 102, respectively. The mean age was 63.39
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Table 4
Frequency Table: Age Distribution of CKD Population
Age
Mean
Median
Std. Deviation
Range
Minimum
Maximum

63.39
65
14.107
82
20
102

Saint Lucia has 11 districts: Anse La Raye, Canaries, Castries, Choiseul, Dennery,
Forest Reserve, Gros Islet, Laborie, Micoud, Soufriere, and Vieux Fort. For this study,
District 6, a Forest Reserve, was omitted because none of the Saint Lucian population
reside in this geographical area. As shown in Table 4, the largest CKD population
districts were the three major cities, Castries, Vieux Fort, and Gros Islet. Castries, which
is the capital city, located to the north of the island, comprised 33.5% of the CKD
population (328 of the total CKD population), Vieux Fort, the second-largest city, located
to the south of the island, comprised 22.4% of the CKD population (219 of the total CKD
population). Gros Islet, a city in the north of the island, comprised 13.4% of the CKD
population (131 of the total CKD population).
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Table 5
Frequency Table: Geographical Location of CKD Population
District

Anse La Raye

Frequency

Percent

Valid Percent

28

2.9

2.9

Cumulative
Percent
2.9

Canaries

1

0.1

0.1

3

Castries

328

33.5

33.5

36.5

Choiseul

39

4

4

40.4

Dennery

92

9.4

9.4

49.8

Gros Islet

131

13.4

13.4

63.2

Laborie

47

4.8

4.8

68

Micoud

58

5.9

5.9

74

Soufriere

36

3.7

3.7

77.6

Vieux Fort

219

22.4

22.4

100

Total

979

100

100

The kidneys of individuals diagnosed with CKD do not usually fail at once.
Kidney disease often progresses slowly over five years. Consequently, if CKD is detected
early, medication and lifestyle changes may slow its progression (CDC, 2019). The NKF
(2020) divided kidney disease into five stages. The GFR is the best measure of kidney
function. The GFR is calculated using the math formula, including a person’s age, race,
gender, and serum creatinine (NKF, 2020). The NKF (2020) further explains that
Creatinine is a waste product that comes from muscle activity. When kidneys are working
well, they remove creatinine from the blood as kidney function slows and creatinine
levels rise. The five stages of CKD are presented in Figure 4. The GFR number tells how
much kidney function is left. As the disease worsens, the GFR number decreases.
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Figure 4
Stages of Chronic Kidney Disease

Note. The National Kidney Foundation, 2020
As shown in Table 6, the Saint Lucian CKD population falls within these five
groups or stages. Stage 1 and 2 comprise 2 (0.2%) and 7 (0.7%) individuals respectively.
The second-largest group was at Stage 3, representing 41.6% of the CKD population (407
of the total CKD population). Stage 4 comprised 13.7% of the CKD population (134 of
the total CKD population). As revealed in this study, the largest group was Stage 5 or
ESRD, accounting for 43.8% of the CKD population in Saint Lucia (429 of the total
CKD population).
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Table 6
Frequency Table: CKD Stage of CKD Population

Stage 1
Stage 2
Stage 3
Stage 4
ESRD/Stage 5
Total

Frequency
2
7
407
134
429
979

CKD Stage
Percent
0.2
0.7
41.6
13.7
43.8
100

Valid Percent
0.2
0.7
41.6
13.7
43.8
100

Cumulative Percent
0.2
0.9
42.5
56.2
100

CKD patients were treated at any one of the three hospitals’ dialysis clinics. From
2015 to 2019, Tapion Hospital (Private hospital) treated 0.9% of the CKD population (9
of the total CKD population). St. Jude Hospital (Statutory hospital) treated 36.1% of the
CKD population (353 of the total CKD population), and Owen King European Union
Hospital (the major public hospital on the island) treated 63% of the CKD population
(617 of the total CKD population) for the same period. It is not surprising that the Owen
King European Union Hospital served the most significant CKD population. It is the only
major public hospital in Saint Lucia situated in one of the most populated regions. Table
7 clearly outlines the frequency distribution of the CKD population across hospitals.
Table 7
Frequency Table: Attending Hospital
Frequency
Tapion Hospital
OKEU Hospital
St. Jude Hospital
Total

9
617
353
979

Hospital
Percent
0.9
63
36.1
100

Valid Percent
0.9
63
36.1
100

Cumulative
Percent
0.9
63.9
100

Upon assessing the data set, the cause of CKD for that population was a myriad of
conditions. As a result of the long list of causes of CKD for those analyzed in this data
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set, I categorized the causes into eight categories: Category 1: Hypertension and Diabetes
Mellitus with no other preexisting cause, category 2: Hypertension with no other
preexisting cause; category 3: Diabetes Mellitus with no other preexisting cause, category
4: Hypertension, Diabetes Mellitus and other combinations such as polycystic kidney
disease (PKD), congestive heart failure (CHF), angina, prostate cancer, peripheral venous
disease (PVD), Parkinson, and metabolic syndrome; category 5: Hypertension and other
combinations such as, polycystic kidney disease, morbid obesity, dyslipidemia, prolapse
uterus, glaucoma, valvopathy, seizure disorder, venous insufficiency, cerebral aneurysm,
acute kidney injury, and proteinuria, hematuria and pagets; category 6: Diabetes Mellitus
and other combinations such as, solitary kidney, HIV, glomerulopathy, and
nephrolithiasis; category 7: Other causes such as, PKD, CHF, calculus, sickle cell
disease, lupus, chronic venous ulcers, immunocompromised, obesity, multiple myeloma,
kidney stones, and depression. The final category comprised unknown cause.
As shown in Table 8, the most common cause of CKD was a combination of
hypertension and diabetes mellitus with no other cause, accounting for 40.6% of the CKD
population (397 of the total CKD population). The second most common cause of CKD
was hypertension only, accounting for 25.5% of the CKD population examined (250 of
the total CKD population). The third most common cause of CKD was a combination of
hypertension, diabetes mellitus, and other diseases or conditions, accounting for 12.9% of
the CKD population (126 of the total CKD population). According to this data, the fourth
leading cause of CKD was hypertension and a combination of other diseases or
conditions, accounting for 10.4% of the CKD population (102 of the total CKD
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population). CKD caused by diabetes mellitus alone accounted for 2.9% of the CKD
population (28 of the total CKD population), and diabetes mellitus with a combination of
other diseases or conditions accounted for 1.6% of the CKD population (16 of the total
CKD population). CKD caused by other conditions or diseases other than hypertension
and or diabetes mellitus accounted for 5.5% of the CKD population (54 of the total CKD
population). Finally, 0.6% of CKD was caused by unknown conditions or diseases in this
study (6 of the total CKD population).
Table 8
Frequency Table: Cause of CKD

HTN, DM
HTN
DM
HTN, DM, Combinations
HTN, Combinations
DM, Combinations
Other Causes
Unknown
Total

Frequency
397
250
28
126
102
16
54
6
979

Cause of CKD
Percent
40.6
25.5
2.9
12.9
10.4
1.6
5.5
0.6
100

Valid Percent
40.6
25.5
2.9
12.9
10.4
1.6
5.5
0.6
100

Cumulative Percent
40.6
66.1
68.9
81.8
92.2
93.9
99.4
100

Note. “DM” refers to Diabetes Mellitus and “HTN” refers to Hypertension.
One of the independent variables that this study sought to examine was
employment. As shown in Table 9, from the total of 979 CKD patients in this study,
20.8% had some form of employment (204 of the total CKD population). The majority of
the CKD population were unemployed, accounting for 79.2% of the CKD population
(775 of the total CKD population). These findings will be further explained later on in
this section.
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Table 9
Frequency Table: Employment Status of CKD Population
Frequency
204
775
979

Yes
No
Total

Employment Status
Percent
Valid Percent
20.8
20.8
79.2
79.2
100
100

Cumulative Percent
20.8
100

Saint Lucia does not have a national health insurance program for its citizens
covering care for CKD patients. Therefore such individuals seek coverage from private
insurance companies. Consequently, most individuals who have some form of medical
insurance would obtain this as a benefit of their employment. As shown in Table 10, most
of the CKD population were uninsured in this study. 94.6% of the CKD population had
no form of medical insurance, accounting for 926 of the total CKD population. Only
5.4% of the CKD population had some form of insurance (53 of the total CKD
population). These findings will be further explained later on in this section.
Table 10
Frequency Table: Insurance Status of CKD Population

Frequency
Yes
No
Total

53
926
979

Insurance
Percent
5.4
94.6
100

Valid Percent

Cumulative Percent

5.4
94.6
100

5.4
100

A very significant variable in this study was subsidization for dialysis. For a basic
overview of this variable, frequency distribution was performed. As was shown in Tables
9 and 10, very few CKD patients are employed and or have medical insurance. As a
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result of the prevalence and incidence of CKD in Saint Lucia, the government has
implemented a dialysis subsidization program to assist patients in treating this disease
(Government of Saint Lucia, 2018).
Table 11 shows the number of CKD patients receiving full subsidization, partial
subsidization, and no subsidization. 66.1% received no subsidization (representing 647 of
the total CKD population). These individuals consisted of persons at stages 1 to 4 who
did not receive dialysis (only Stage 5 or ESRD receive dialysis treatment), persons who
rejected treatment, and persons at stage 5 or ESRD awaiting treatment. Further analysis
of this variable is presented.

Table 11
Frequency Table: CKD Population Receiving Subsidization for Dialysis
Frequency

Subsidization
Percent

Valid Percent

Cumulative Percent

None
Full Subsidization

647
64

66.1
6.5

66.1
6.5

66.1
72.6

Partial Subsidization

268

27.4

27.4

100

Total

979

100

100

Table 12
Frequency Table: CKD Population Accessing Dialysis
Dialysis Utilization
Frequency

Percent
71.4
0.1

Valid
Percent
71.4
0.1

Cumulative
Percent
71.4
71.5

None
Once a Week

699
1

Twice a Week

51

5.2

5.2

76.7

Three times a Week

228

23.3

23.3

100

Total

979

100

100

Note. “None” (699) refers to CKD patients within stages 1-4, who are not being dialyzed.
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Table 13
Multiple Logistic Regression for Combined Variables: Case Summary
Case Processing Summary
Unweighted Cases
Selected Cases

N
979
0
979
Unselected Cases
0
Total
979
a. If weight is in effect, see classification table for the total number of cases.

Percent
100.0
0.0
100.0
0.0
100.0

Included in Analysis
Missing Cases
Total

Note. This table shows the number of cases considered in this test. It includes 979 cases
with 0 cases excluded or missing.
Table 14 shows encoding for the dependent variable, dialysis utilization. The
binary coding, yes =1; “meaning uses Dialysis,” No=0; “meaning not using Dialysis.”
This also meant that the model would be predicting the odds of ‘Yes”, or the odds of
dialysis utilization as the answer "Yes" had been given the larger internal value code in
the model. Yes =1, No=0.
Table 14
Dependent Variable Coding
Dependent Variable Encoding
Original Value

Internal Value

No

0

Yes

1

Note. Dialysis Utilization Coding for logistic regression analysis
Table 15 shows a standard correlation matrix as performed in SPSS for the
independent variables (Employment, Insurance, and Subsidization) and dependent
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variable (dialysis utilization) in the study. This step is important before running the
multiple logistic regression to determine and treat (if necessary) for multicollinearity in
independent variables. Multicollinearity will cause unstable estimates and inaccurate
variances that affect confidence intervals and hypothesis tests (Senaviratna & Cooray,
2019)
Table 15
Correlation Table
Correlations
EMPLOYMENT
EMPLOYMENT

Pearson
1
Correlation
Sig. (2tailed)
N
979
INSURANCE
Pearson
.389**
Correlation
Sig. (20
tailed)
N
979
SUBSIDIZATION
Pearson
-.136**
Correlation
Sig. (20
tailed)
N
979
DIALYSIS
Pearson
-.108**
UTILIZATION
Correlation
Sig. (20.001
tailed)
N
979
**. Correlation is significant at the 0.01 level (2-tailed).

INSURANCE

SUBSIDIZATION

.389**

-.136**

DIALISYS
UTILIZATION
-.108**

0

0

0.001

979
1

979
-0.028

979
-0.048

0.38

0.135

979
1

979
.777**

979
-0.028
0.38

0

979
-0.048

979
.777**

0.135

0

979

979

Multicollinearity happens in a regression model when the independent variables
are correlated. The degree of change in one variable is closely affected by the change in
another independent variable. If the degree of correlation is high and not corrected, this
may result in undesirable results after running the regression analysis (Frost, 2021).
Although it was observed that there was some correlation between employment and

979
1

979
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insurance (p= .389) and employment and subsidization (p= -.136) however, observing the
correlation table was not enough to explain multicollinearity between these variables and
therefore the study applied further analysis of the collinearity statistics tolerance and its
reciprocal called the variance inflation factor (VIF) as shown in Table 16.

Table 16
Collinearity Statistics: Coefficients
Model

1

(Constant)
EMPLOYMENT
INSURANCE

Unstandardized
Coefficients
B
Std.
Error
0.14
0.08
0.01
0.025
-0.06
0.044

SUBSIDIZATION
0.397
0.01
a. Dependent Variable: Dialysis Utilization

Coefficientsa
Standardized
Coefficients
Beta

t

Sig.

Collinearity Statistics
Tolerance

VIF

0.009
-0.029

1.746
0.417
-1.349

0.08
0.68
0.18

0.833
0.848

1.2
1.179

0.777

38.21

0

0.981

1.02

In the collinearity statistics, tolerance measures the percentage of the variance in a
given predictor variable (employment, insurance, subsidization) that the other predictors
cannot explain. Although there is no formal threshold value for this, the literature
suggests that a tolerance below 0.2 suggests serious collinearity (Senaviratna et al.,
2019). The Collinearity statistic for all of the independent variables in Table 16 is closer
to 1, meaning that there is very little correlation between them.
Further, the VIF shows how much the variance of the coefficient estimate is
inflated by multicollinearity. Again, like the tolerance statistic, there is no formal cutoff
value for the VIF for determining multicollinearity. However, it is generally accepted that
values of VIF that exceed 10 indicate multicollinearity. In logistic regression, values
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above 2.5 may cause concern (Midi et al., 2010). In this study, the VIF numbers were
below the considered 2.5 threshold for all variables in the model.
The findings of the collinearity statistics of tolerance and the variance inflation
factor for all of the independent variables led to the conclusion that correlation among
these variables was not substantial. Therefore these variables could not be voided during
the process of performing the multiple logistic regression and hypothesis testing to
answer the associated RQs.
The Categorical Variables Coding Table 17 shows the frequencies of the various
independent variables that were forced into the model. In the independent variable
category, subsidization, 647 patients received no subsidization. Of the 332 that receive
subsidization, 268 patients received partial subsidization, and 64 patients received full
subsidization. In the insurance category, 926 patients were uninsured, and 53 patients
were insured. In the employment category, 775 patients were unemployed, and 204 were
employed.
Table 17
Logistic Regression: Independent Variable Coding
Categorical Variables Codings
Frequency

Parameter coding
(1)

SUBSIDIZATION
INSURANCE
EMPLOYMENT

No

647

1

Yes

332

0

yes

53

1

No

926

0

Yes

204

1

No

775

0
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It revealed each independent variable's categories, manually recoded into the
regression as dummy variables under parameter coding (1). In logistic regression, just as
in linear regression, groups are compared to each other. One group has to be omitted
from the comparison to serve as the baseline category (Creswell & Creswell, 2018). In
this case, for each independent variable, one dummy variable was selected as the
constant. In subsidization, “No” was selected as constant, to which predictions for “Yes”
were compared. Likewise, in insurance, "No" was constant to which predictions for Yes
were compared in this category, and employment "No" was selected automatically,
against which employment "Yes" were compared.
Table 18
Classification Table
Classification Tablea,b
Observed

Dialysis Utilization

No
Yes

Overall Percentage
a. Constant is included in the model.
b. The cut value is .500

Predicted
Dialysis Utilization
Percentage Correct
No
Yes
698
0
100.0
281
0
0.0
71.3

Table 18 shows predictions for the dependent variable “use of dialysis” without
introducing any independent variables into the regression. In other words, the odds that a
patient may not use dialysis without taking into account employment, insurance, or any
level of subsidization was predicted at roughly 71.3%. For example, suppose a case
would be selected randomly from the CKD cases in Saint Lucia. In that case, the
likelihood of selecting someone who does not use dialysis is predicted at 71.3% higher
compared to selecting someone who uses dialysis. This reflects the existing ratio of
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dialysis non-users compared to persons using dialysis in the sample. Numerically

represented as:

Table 19
Variables in the Equation
Variables in the Equation
B
Constant

S.E.
-0.910

Wald

0.071

df

165.856

Sig.
1

Exp(B)

0.000

0.403

In Table 19, the Odds of dialysis utilization by a CKD patient is shown. The odds
ratio represented by the Exponential B; Exp(B) means that without the addition of any of
the independent variables, the odds of using dialysis was predicted at 0.403, representing
the odds that a CKD patient would not use dialysis.
Table 20
Multiple Regression model
Multiple Regression Table

Variables

Score

df

Sig.

EMPLOYMENT(1)

11.443

1

0.001

INSURANCE(1)

2.234

1

0.135

679.773

1

0.000

681.31

3

0.000

SUBSIDIZATION (1)
Overall Statistics

Table 20 shows the significance of each independent variable related to the
dependent variable, dialysis utilization. For satisfying the logistic regression
requirements, two variables in this analysis were recoded from their original multiple tier
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responses to binary coding1. If "P" (Sig.) is less than 0.05, then the model determines that
these independent variables' relationship to the dependent variable is significant. In this
case significance of the independent variable, employment is lower than the threshold of
0.05; therefore, it is significant, just as is the case with subsidization. Insurance was not
significant in the model with a p-value of 0.135, which is above the threshold of 0.05.
This may be influenced by the comparatively low number of patients with insurance in
the model. However, this multiple logistic regression model had an overall significance
level of 0.00, meaning that the independent variables (Employment and Subsidization)
did influence dialysis utilization. This was supported by the results of the Omnibus Tests
of Model Coefficients in Table 21. Each of these independent variables will also be
individually tested (Chi-square test) against the dependent variable (dialysis utilization)
to determine the strength of significance and respond to each RQ separately.
Table 21
Omnibus Tests of Model Coefficients
Omnibus Tests of Model Coefficients
Step 1

Step
Block
Model

Chi-square
771.795
771.795
771.795

Df
4
4
4

Sig.
0.000
0.000
0.000

Note. Block 1: Method =Enter
Table 21 shows the multiple logistic regression results, including both dependent
variable (dialysis utilization) and Independent Variables (Employment, Insurance, and

•
•

Dialysis Utilization was recoded from responses “0=None, 1= Once Weekly, 2=Twice Weekly, 3 = Three
times weekly”, to Binary coding “0=No” for None, and “1=Yes”, for all responses other than None.
Subsidization was recoded from responses “0=None, 1= Full subsidization, 2=Partial Subsidization” to
Binary coding “0=No”for None and “1=Yes”, for all responses other than None.
1
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Subsidization). The "Omnibus Tests of Model Coefficients" show the result of a chisquare test to determine whether or not the independent variables' addition has a
statistically significant relationship with the dependent variable (Creswell & Creswell,
2018), dialysis utilization. This chi-square Test returned the value of 0.000, indicating a
statistically significant relationship between dialysis utilization and employment and
dialysis utilization and subsidization.
Table 22 provides pseudo-R-squared measures of Cox & Snell and Nagelkerke.
These R-Square measures inform on the variability in the dependent variable (Creswell &
Creswell, 2018); dialysis utilization was explained by the independent variables,
employment, and subsidization. Cox & Snell R-squared determines that this model
explains 54.5% of the variation in dialysis utilization. In contrast, Nagelkerke R-Squared
determines that this model explains 78.1% variation in dialysis utilization. In both
instances, however, this reveals implicitly that other factors outside of this model
influence dialysis utilization.
Table 22
Cox & Snell and Nagelkerke R Square Measures
Model Summary
Step

-2 Log likelihood

Cox & Snell R Square

Nagelkerke R
Square
1
401.965a
0.545
0.781
a. Estimation terminated at iteration number 7 because parameter estimates changed by
less than .001.

The Pearson chi-square significance level of 0.135, shown in Table 23, was above
the recommended significance level of 0.05, indicating that the association between
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insurance and dialysis utilization was not significant. Insurance in the model is not a
significant predictor of dialysis utilization.

Table 23
Chi-Square Tests
Value

Chi-Square Tests
df
Asymptotic Significance
(2-sided)
1
0.135
1
0.181
1
0.145

Exact Sig.
(2-sided)

Exact Sig.
(1-sided)

Pearson Chi-Square
2.234a
Continuity Correctionb
1.792
Likelihood Ratio
2.125
Fisher's Exact Test
0.159
Linear-by-Linear
2.232
1
0.135
Association
N of Valid Cases
979
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 15.21.
b. Computed only for a 2x2 table

0.092

Further, the eta statistic application to measure the level of variability in the
dependent variable accounted for by the independent variable is reported in Table 24.
Table 24 shows the crosstabs for independent variable Insurance against
dependent variable, dialysis utilization. The observed and expected count values for
dialysis utilization (Yes, No) were recorded against Insurance (Yes, No). The expected
count shows what should be expected or observed if the independent variable had no
relationship to the dependent variable. The chi-square test helps determine if the observed
counts are different enough for the association between these two variables to be
significant (Creswell & Creswell, 2018).
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Table 24
Crosstabulation: Dialysis Utilization and Insurance
Dialysis Utilization * INSURANCE Crosstabulation

Dialysis Utilization

No

Count
Expected Count
Count
Expected Count
Count
Expected Count

Yes
Total

INSURANCE
yes
No
33
665
37.8
660.2
20
261
15.2
265.8
53
926
53.0
926.0

Total
698
698.0
281
281.0
979
979.0

Table 25
Chi-Square Test
Chi-Square Tests
Value

Df

Asymptotic
Significance (2sided)
0.135
0.181
0.145

Exact Sig.
(2-sided)

Pearson Chi-Square
2.234a
1
Continuity Correctionb
1.792
1
Likelihood Ratio
2.125
1
Fisher's Exact Test
0.159
Linear-by-Linear
2.232
1
0.135
Association
N of Valid Cases
979
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 15.21.
b. Computed only for a 2x2 table

Exact Sig.
(1-sided)

0.092

The Pearson chi-square significance level was at 0.135, as shown in Table 25,
above the recommended significance level of 0.05, which indicates that the association
between insurance and dialysis utilization is not significant. Insurance in the model is not
a significant predictor of dialysis utilization. RQ1 and its associated hypotheses were as
follows:
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RQ1: What is the relationship, if any, between health insurance and dialysis
utilization for CKD patients when controlling for age, race, gender, geographical
location, CKD stage, CKD cause, and attending hospital in Saint. Lucia?
H01: There is no statistically significant relationship between health insurance and
dialysis utilization for CKD patients when controlling for age, race, gender,
geographical location, CKD stage, CKD cause, and attending hospital in Saint
Lucia.
Ha1: There is a statistically significant relationship between health insurance and
dialysis utilization for CKD patients when controlling for age, race, gender,
geographical location, CKD stage, CKD cause, and attending hospital in Saint.
Lucia.
Based on the “P” value of 0.135 from the multiple regression model (Table 20)
and the Pearson chi-square significance level of 0.135 (Table 23), insurance did not have
a statistically significant relationship with dialysis utilization; therefore, the null
hypothesis for RQ could not be rejected. Therefore, dialysis utilization is not necessarily
dependent on whether or not a patient has Insurance in this study. While the relationship
did not meet the threshold for statistical significance, it did “approach significance.” This
may be reflective of the comparatively low number of patients with insurance. Further,
the Eta Statistic application to measure the level of variability in the dependent variable
accounted for by the independent variable is reported in Table 26.
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Table 26
Eta Statistic for Insurance
Directional Measures
Nominal by Interval

Eta

Dialysis Utilization
Dependent
INSURANCE Dependent

Value
0.048
0.048

Eta-squared is the most typically reported measure of effect size in measuring
variance analysis (Creswell & Creswell, 2018). It represents the percentage of variance in
the dependent variable accounted for by the independent variable. Eta-Squared as regards
to the effect of insurance in dialysis utilization was; η2 = 0.0482 = 0.002304 * 100 =
0.23%. Only 0.23% (less than half a percent) of the dialysis utilization variance was
accounted for by insurance.
The Pearson Chi-Square significance level is at 0. 001 as shown in Table 28. This
was below the recommended significance level of 0.05, indicating that the association
between employment and dialysis utilization is significant. Employment in the model is a
significant predictor of dialysis utilization.
Table 27
Crosstabulations: Dialysis Utilization and Employment

Dialysis Utilization

Dialysis Utilization * EMPLOYMENT Crosstabulation
EMPLOYMENT
Yes
No
No
Count
126
572
Expected Count
145.4
552.6
Yes

Total

Total
698
698

Count
Expected Count

78
58.6

203
222.4

281
281

Count
Expected Count

204
204

775
775

979
979
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Table 28
Chi-Square Tests: Dialysis Utilization and Employment
Value

Chi-Square Tests
df
Asymptotic
Significance (2sided)
1
0.001

Exact Sig. (2sided)

Exact Sig. (1sided)

Pearson Chi11.443a
Square
Continuity
10.862
1
0.001
Correctionb
Likelihood Ratio
10.995
1
0.001
Fisher's Exact Test
0.001
Linear-by-Linear
11.431
1
0.001
Association
N of Valid Cases
979
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 58.55.
b. Computed only for a 2x2 table

0.001

RQ2 and its associated hypotheses were as follows:
RQ2: What is the relationship, if any, between employment and dialysis
utilization for CKD patients when controlling for age, race, gender, geographical
location, CKD stage, CKD cause, and attending hospital in Saint. Lucia?
H02: There is no statistically significant relationship between employment and
dialysis utilization for CKD patients when controlling for age, race, gender,
geographical location, CKD stage, CKD cause, and attending hospital in Saint.
Lucia.
Ha2: There is a statistically significant relationship between employment and
dialysis utilization for CKD patients when controlling for age, race, gender,
geographical location, CKD stage, CKD cause, and attending hospital in St.
Lucia.
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The model does present a degree of significance enough to reject the Null
Hypothesis, H02. Therefore, dialysis utilization is somewhat influenced by whether or not
a patient is employed. The relationship between employment and dialysis utilization is
statistically significant. Further application of the Eta Statistic to measure the level of
variability in dialysis utilization accounted for by the employment is reported in Table 29.
Eta-squared is the most typically reported measure of effect size in measuring
analysis of variance. It represents the percentage of variance in the dependent variable
accounted for by the independent variable. Eta-Squared as regards to the effect of
employment on dialysis utilization is; η2 = 0.1082 = 0.011664 * 100 = 1.16%. at least
1.16% of the variance in dialysis utilization is accounted for by employment.

Table 29
Directional Measures: Dialysis Utilization and Employment
Directional Measures
Nominal by Interval

Eta

Dialysis Utilization Dependent
EMPLOYMENT Dependent

Value
0.108
0.108
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Table 30
Crosstabulations: Dialysis Utilization and Subsidization
Dialysis Utilization * SUBSIDIZATION Crosstabulation
SUBSIDIZATION
None
Full
Partial
Subsidization
Subsidization
Dialysis Utilization
No
Count
636
1
61
Expected
461.3
45.6
191.1
Count
Yes
Count
11
63
207
Expected
185.7
18.4
76.9
Count
Total
Count
647
64
268
Expected
647
64
268
Count

Total

698
698
281
281
979
979

Table 31
Chi-Square Tests: Dialysis Utilization and Subsidization
Chi-Square Tests
Value
Df
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases

691.118a
764.511
590.234

2
2
1

Asymptotic Significance (2sided)
0.000
0.000
0.000

979

a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 18.37.

The Pearson chi square significance level was at 0.000, below the recommended
significance level of 0.05. This indicates that the association between subsidization and
dialysis utilization is significant. Subsidization in the model is a significant predictor of
dialysis utilization. RQ3 and its associated hypotheses were as follows:
RQ3: What is the relationship, if any, between government subsidization and
dialysis utilization for CKD patients in Saint Lucia?
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H03: There is no statistically significant relationship between government
subsidization and dialysis utilization for CKD patients in Saint Lucia.
Ha3: There is a statistically significant relationship between government
subsidization and dialysis utilization for CKD patients in Saint Lucia.
The model does present a degree of significance enough to reject the null
hypothesis, H03. Therefore, dialysis utilization is influenced by whether or not a patient
received subsidies for dialysis. The relationship between subsidization and dialysis
utilization was statistically significant.
Further application of the Eta Statistic to measure the level of variability in
dialysis utilization accounted for by the Subsidization is reported in Table 32.
Table 32
Directional Measures: Dialysis Utilization and Subsidization
Directional Measures
Nominal by Interval

Eta

Dialysis Utilization Dependent

Value
0.84

SUBSIDIZATION Dependent

0.777

Eta-squared is the most typically reported measure of effect size in measuring
analysis of variance. It represents the percentage of variance in the dependent variable
accounted for by the independent variable. Eta-Squared as regards to the effect of
subsidization on dialysis utilization is; η2 = 0.7772 = 0.603729 * 100 = 60.37%. Roughly
60% of the variance in dialysis utilization was accounted for by subsidization.
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Summary
Through the various statistical analyses of logistic regression, chi-square, and
crosstabulation, the three RQs for this study were answered. For RQ1, there was no
statistically significant relationship between health insurance and dialysis utilization for
CKD patients when controlling for age, race, gender, geographical location, CKD stage,
CKD cause, and attending hospital in Saint. Lucia. Insurance was not statistically
significant in the multiple regression model with a p-value of 0.135, which is higher than
the threshold of 0.05. Additionally, the Pearson chi-square significance level of 0.135
was above the recommended significance level of 0.05 in the model. This revealed that
the association between insurance and dialysis utilization was not significant and that
insurance in the model was not a significant predictor of dialysis utilization.
Further, the Eta Statistic application measures variability in the dependent
variable accounted for by the independent variable. In this study, only 0.23% (less than
half a percent) of the dialysis utilization variance was accounted for by insurance.
Therefore, the null hypothesis (H01) was not rejected. The data concluded that dialysis
utilization was not dependent on whether or not a patient had insurance.
The null hypotheses (H02, H03) for RQs 2 and 3 were rejected, and the alternative
hypotheses were accepted. This study revealed a statistically significant relationship
between employment and dialysis utilization and between subsidization and dialysis
utilization. The multiple regression model (Table 20) returned the value of 0.000,
respectively, for dialysis utilization and employment and dialysis utilization and
subsidization, indicating a statistically significant relationship.
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For RQ2, the Pearson chi-square significance level was 0.001, below the
recommended significance level of 0.05, indicating that the association between
employment and dialysis utilization is significant. Employment in the model is a
significant predictor of dialysis utilization. Eta-squared regarding the effect of
employment on dialysis utilization was 1.16%., meaning at least 1.16% of the variance in
dialysis utilization was accounted for by employment.
The Pearson chi-square significance level of 0.000 was below the recommended
significance level of 0.05, indicating that the association between subsidization and
dialysis utilization was statistically significant. Subsidization in the model was a
statistically significant predictor of dialysis utilization. Eta squared as it pertained to the
effect of subsidization on dialysis utilization was equal to 60.37%. Roughly 60% of the
variance in dialysis utilization was accounted for by subsidization. These significant
findings reveal the efficacy of the government’s subsidization program for dialysis
treatment for CKD patients. Additionally, the findings also point out that employment
status influenced dialysis utilization among CKD patients in Saint Lucia. These results
provide relevant and valuable information to CKD patients' management and care in
Saint Lucia.

77
Section 4: Application to Professional Practice and Implications for Social Change
Introduction
In this study, I applied a quantitative approach with a correlational analysis to
determine whether a relationship existed between the independent variables, health
insurance, employment, subsidization, and the dependent variable, dialysis utilization.
The purpose of the study was to assess the efficacy of the government’s subsidization
program for dialysis in Saint Lucia and the utilization of hemodialysis given a patient’s
employment status, health insurance status, or receipt of government subsidization.
Additionally, an assessment of the CKD population's baseline characteristics in was
carried out for the first time. I begin this section by interpreting the findings, followed by
this study's limitations, then the recommendations, and finally, the study’s implications
for professional practice and social change.
Interpretation of the Findings
This study's specific problem was the financial barriers that affect dialysis
utilization in managing CKD patients in Saint Lucia. According to my research, this
project was unique because it was the first to be specific to this population. This study
was also motivated by my desire to understand better the CKD population's specific
baseline characteristics in Saint Lucia and the impact of payment models on dialysis
utilization. Given that government dialysis subsidization has been in effect since 1999, it
was essential to assess this program's efficacy, which is essential to the effective
management of CKD (Government Information Service, 2015).
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The frequency tables provide first-time insight into some of the characteristics of
the CKD population in Saint Lucia. I found that there was a higher percentage of females
than males diagnosed with CKD in this study. Previous population-based studies indicate
a higher prevalence of CKD in women (Brar & Markell, 2019); however, men were
found to progress more rapidly to ESRD (Brar & Markell, 2019; Chang et al., 2016; De
Rosa, et al., 2017). The literature further suggests that fewer males were screened for
CKD or monitored conditions such as hypertension and diabetes, leading to CKD's onset
(Chen et al., 2019). Consequently, this study suggests that lifestyle-related factors may
also play a role in CKD's development and progression. Another finding of this study was
that CKD's major causes in Saint Lucia were hypertension and diabetes. Support from the
literature suggests that CKD is most commonly attributed to hypertension and diabetes
worldwide (Chen et al., 2019; Kramer et al., 2018). I also found that the average age of
CKD patients was 63 years. Noble and Taal (2019) postulated that CKD affects 13% of
the adult population globally and that the prevalence rises significantly with age. Chen et
al. (2019) also substantiated this finding by stating that kidney function deteriorates with
aging. This finding is of significance, primarily because Saint Lucia’s average age for
CKD falls below the average global age of 65 years, according to the CDC (2020).
It was not surprising that the most densely populated districts in Saint Lucia,
namely Castries, Vieux Fort, and Gros Islet, had the highest CKD patients. Districts
situated in the outskirts of the cities and rural areas, such as Canaries and Anse La Raye,
were reported to have fewer CKD patients. Over 90% of CKD patients in this study were
of African descent, which mirrors the general population’s ethnic or racial distributions
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(Pan American Health Organization, 2019). Another important finding of this study was
the distribution of patients across CKD Stages 1 to 5. The majority of CKD patients were
at Stages 3 and 5 (ESRD), followed by Stage 4, with fewer in the other stages. According
to Chen et al. (2019), less than 5% of patients with early CKD report their disease
awareness. The majority become aware when they are at advanced stages and
symptomatic (Caribbean Renal Registry, 2018; George et al., 2017). Chen et al. could
also explain why the numbers in this study were higher at these stages. From the
frequencies reported on the causes of CKD, CKD's most common cause in Saint Lucia
was a combination of hypertension and diabetes, accounting for 40.6% of the population
examined, followed by patients with hypertension only. These results are significant
because they provide essential information about the influence of lifestyle-related factors
on CKD. Goro et al. (2019) suggest that CKD's burden disproportionately impacts
LMICs, where diabetes and hypertension are the most significant risk factors for the
CKD growth rate.
Though this study did not include a complete exploration of the gaps and
inequities in renal treatment therapy, hemodialysis provided relevant information and
answered the RQs. The focus of RQ1 was on determining whether there was a
statistically significant relationship between health insurance and dialysis utilization.
There was no statistically significant relationship between health insurance and dialysis
utilization for CKD patients when controlling for age, race, gender, geographical
location, employment status, CKD stage, and attending hospital in Saint. Lucia. Insurance
did not appear to be significant for both the multiple regression and Pearson chi-square
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models with a low p-value of 0.135, reflective of the comparatively low number of
patients with insurance in the study.
Consequently, the null hypothesis for RQ1 (H01) could not be rejected. Therefore,
dialysis utilization is not necessarily dependent on whether or not a patient has insurance.
To further determine the percentage of variance in dialysis utilization accounted for by
insurance, the eta-squared percentage was calculated. Less than half a percent of the
variance in dialysis utilization was accounted for by insurance. Consequently, R-Squared
measures (Cox & Snell and Nagelkerke) revealed that the influence of employment and
subsidization explained more than 50% of dialysis utilization.
The focus of RQ2 was on determining whether or not there was a statistically
significant relationship between employment and dialysis utilization. This study found
that the majority (more than 50%) of CKD patients on dialysis were unemployed, further
substantiating current literature, which purports that CKD patients with ESRD face many
barriers to remaining in the workforce after starting dialysis (Erickson et al., 2018; Hallab
& Wish, 2018; Krishnan, 2019). In this study, further analysis using multiple regressions
and the Pearson chi-square test revealed a p-value of 0.000, which indicated a statistically
significant relationship between dialysis utilization and employment. Therefore these
findings presented a degree of significance enough to reject the null hypothesis (H02).
Eta-squared for the effect of employment on dialysis utilization accounted for at least
1.16% of the variance in dialysis utilization. This finding is consistent with previous
studies stating that employed persons have increased dialysis utilization than those who
are not employed (Hallab & Wish, 2018; Norton & Eggers, 2020).
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The focus of RQ3 was on examining the relationship between dialysis utilization
and subsidization. I answered this question through logistic regression, chi-square
analysis, and the eta squared statistic. The Pearson chi-square p-value of 0.000 and the
multiple regression p-value of 0.000 revealed that the association between subsidization
and dialysis utilization was statistically significant. That subsidization was a significant
predictor of dialysis utilization. Consequently, dialysis utilization was influenced by
whether or not a patient received government subsidization for dialysis. The eta statistic
application to measure the level of variability revealed that 60% of the variance in
dialysis utilization was accounted for by subsidization. The null hypothesis (H03) was
rejected based on the degree of significance from the statistical measures employed. This
finding was very significant since most CKD patients from the population were
unemployed and uninsured, providing further evidence that the government's dialysis
subsidization program was effective. These findings supported the current literature that
dialysis utilization is significantly impacted by subsidization, particularly among the
unemployed and uninsured CKD population in LMICs (Anderson, 2018; Business View
Caribbean, 2019; Chen et al., 2019; Erickson et al., 2018).
Limitations of the Study
There were several limitations to this research design. Firstly, the data set was
limited to only CKD patients who accessed dialysis from 2015 to 2019. Therefore, the
generalizability of the findings of this study was limited. Secondly, other factors outside
those examined influenced dialysis utilization. Further analysis of the data is encouraged
to determine what other factors contribute to dialysis utilization.
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Additionally, hemodialysis gaps and inequities, which may help better understand
dialysis utilization trends, were not explored. Type of insurance coverage and its
influence on dialysis utilization was not examined. Therefore further examination of a
CKD patient’s type of insurance and its relation to dialysis utilization may provide
greater insight into the impact of insurance on dialysis utilization. Additionally, though
the relationship between insurance and dialysis utilization did not meet the statistical
significance threshold, it did approach significance, leading to the possibility of a
relationship. Further exploration into this relationship is encouraged by using a larger
sample size or extending to other populations.
Recommendations
The study findings revealed a significant relationship between employment,
subsidization, and dialysis utilization. Against the backdrop of a worsening economy,
high unemployment rates, and escalation of health care costs, it was essential to examine
the relationship between the study’s variables. There are several avenues that this
research could be extended to build upon the current findings. One avenue for future
research would be an analysis of CKD progression, more specifically from progression
from stage 3 to stage 5 (ESRD). This may provide important information about the time a
patient takes to progress from one stage to another, providing pertinent information to
improve quality care outcomes. Further examination of the factors other than insurance,
employment, and subsidization that influence dialysis utilization is recommended.
Factors such as socioeconomic status or educational background may be considered.
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A more in-depth examination of demographics, ethnicity, and compliance to
dialysis treatment is also recommended. This study could also be extended to
investigating CKD incidence in Saint Lucia to help predict future cases, mainly because
utilization heavily depends on government subsidization. This study may provide
relevant information to health officials and other stakeholders in decision-making for the
current subsidization program. The majority of CKD patients in this study were at stages
5 (ESRD) or 3. Further investigation may help determine the factors contributing to
CKD progression, particularly from stage 3 to ESRD.
Implications for Professional Practice and Social Change
Despite the inescapable financial obligations faced by CKD patients, their
families, and the government in assisting in accessing dialysis treatment, the reality is
that poor management of this condition invariably leads to even more financial burdens.
According to De Rosa et al. (2017), patients with CKD are at high risk for developing
other critical conditions that most often warrant admission to intensive care units. Saint
Lucia’s already burdened health care system is not exempt from the increasing
hospitalizations and critical care sought by CKD patients. This is further substantiated by
this study’s findings of CKD's causes, thus leading to more economic burdens
(Government of Saint Lucia, 2018). In the wake of health reform initiatives, an integrated
multidisciplinary effort is necessary to adequately manage such patients' multi-organ
damage (De Rosa et al., 2017). Current research about CKD proves vital information to
decision-makers to develop more appropriate strategies to address this chronic disease.
Health leaders, governments and other stakeholders should recognize the true situation of
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CKD management in Saint Lucia. The government can only subsidize dialysis treatment
for only a finite number of CKD patients. As a result, this should motivate exploration of
other preventative programs that may assist in modifying the general population's
lifestyle choices to prevent the onset and further progression of CKD. Other studies have
established an association between a healthy lifestyle with decreased CKD risk and
mortality in the general population (Lee et al., 2019; Morton & Sellars, 2019). A recent
study by Evangelidis et al. (2019) proposed that lifestyle behavior change interventions
for CKD patients can prevent disease progression. Consequently, such initiatives can be
implemented in resource-poor countries, or already overburdened health systems seeking
for alternatives to curtail the increasing costs of health care for CKD patients.
This quantitative study's findings provide insight into the financial barriers that
affect dialysis utilization in managing CKD patients in Saint Lucia. Pertinent information
needed by health leaders and other stakeholders are presented for the first time for this
specific population and non-communicable disease in Saint Lucia. It will add to the
limited research on CKD management related to health delivery (Tamura et al., 2018) in
LMICs. Additionally, this study will inform government health officials, policy makers,
and healthcare leaders of the efficacy of the dialysis subsidization program for CKD
patients in Saint Lucia. This study provides a greater understanding of how government
subsidization has impacted access to dialysis treatment. This study's information may
contribute to health service delivery and implement policies to remedy financial barriers
and improve access and quality of care for CKD patients in Saint Lucia (Wilk, Hirth, &
Messana, 2019). This study's results may also provide information to both government
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and health officials about CKD trends, financial barriers to access care for CKD patients,
and recommendations for policy or social change improvement initiatives.
Furthermore, the study is essentially a policy analysis of government subsidies'
efficacy. Therefore, it is of potential societal relevance, primarily because the findings
reveal that government subsidization positively impacts dialysis utilization.
Consequently, policy makers, healthcare officials, and other stakeholders may obtain
information from this study that can impact future initiatives for payment models and
disease management of CKD in Saint Lucia.
Conclusion
This study, grounded in the Andersen and Newman (1995) Health Services
Utilization Framework, sought to determine whether a relationship existed between
insurance, employment, subsidization, and dialysis utilization. It also sought to
determine, for the first time, the efficacy of the government subsidization program for
dialysis in Saint Lucia and assess the CKD population's baseline characteristics in Saint
Lucia. A literature review indicated that financial barriers such as unemployment, lack of
insurance, and or subsidization are significant factors influencing dialysis utilization,
particularly among LMICs. This study sought to fill the gap between the efficacy of
government subsidization and dialysis utilization in LMICs (Caribbean Renal Registry,
2018; Erickson et al., 2018; Li et al., 2019). While there have been numerous studies on
financial barriers to dialysis utilization, few studies have examined government
subsidization efficacy.
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The research design was a quantitative causal-comparative cohort to investigate
group populations. Same subjects (individuals diagnosed with CKD) across the period
2015-2019 who accessed dialysis treatment at any of the dialysis clinics were compared.
The dependent variable was dialysis subsidization, and the independent variables were
subsidization, employment, and insurance. Covariates included age, race, gender,
geographical location, CKD stage, CKD cause, and attending hospital. The data file for
this study contained no personally identifiable information. Therefore there were no
confidentiality violations. Current research about CKD provides vital information to
decision-makers and other stakeholders in developing more appropriate strategies to
address this chronic disease. Upon recognizing that the government bears the most
significant responsibility for covering the cost of dialysis treatment through its
subsidization program, health officials, government leaders, and other pertinent
stakeholders may begin to explore alternative solutions for sustainability. Based on the
fact that government can only subsidize dialysis treatment for a finite number of CKD
patients, preventative programs may be implemented to modify the general population's
lifestyle choices to prevent further disease progression or even delay the onset. Other
studies have established an association between a healthy lifestyle with decreased CKD
risk and mortality in the general population (Lee et al., 2019; Morton & Sellars, 2019).
Despite the inescapable financial obligations that CKD patients, their families, and the
government face concerning dialysis utilization, the reality is that poor management of
this disease invariably leads to even more financial burdens.
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This study provided a greater understanding of how government subsidization has
impacted access to dialysis treatment. This study's information may contribute to health
service delivery improvements and policies to remedy financial barriers and improve
access and quality of care for CKD patients in Saint Lucia (Wilk, Hirth, & Messana,
2019). This study's results may also provide information to both the government and
pertinent health officials about trends in CKD, financial barriers to accessing care, and
recommendations for policy or social change improvement initiatives. Furthermore, the
study is essentially a policy analysis of the government subsidization program's efficacy.
Therefore, it is of potential societal relevance because the findings reveal that
government subsidization positively impacts dialysis utilization for numerous Saint
Lucians with CKD.
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